Antique Daily 14 Nov 24
Antique Daily 14 Nov 24
STRICTLY CONFIDENTIAL
14 November 2024
ANTIQUE’S MORNING PRESENTATION
FROM THE RESEARCH DESK Market Snapshot
INITIATING COVERAGE Global Indices Closing % Chg % YTD
Allied Blenders and Distillers Dow Jones 43,958 0.1 16.6
NASDAQ 19,231 (0.3) 28.1
Scale up of P&A to drive growth
FTSE 8,030 0.1 3.8
QUARTERLY RESULTS REVIEW
CAC 7,217 (0.1) (4.3)
NMDC DAX 19,003 (0.2) 13.4
EBITDA impacted QoQ by lower volume, inventory swing; 2HFY25 Bovespa 1,27,734 0.0 (4.8)
outlook remains strong Nikkei 38,722 (1.7) 16.6
Alkem Laboratories Hang Seng 19,823 (0.1) 16.3
Shanghai Composite 3,439 0.5 15.6
India formulations revenue growth remains weak
CESC Indian Indices Closing % Chg % YTD
Steady business Sensex 77,691 (1.3) 7.5
YoY higher exports, backward integration supported EBITDA FII F&O Stock Fut Index Fut
Kolte-Patil Developers Net ($ mn) 1,523 135
Catch-up on BD, launches, and margin recovery critical OI (%) - 3.6
Derivatives Update
Long Build Up
Company Last % Chg % Chg OI OI (in 000)
SYNGENE 863.45 3.38 4.55 6,655
LTF 136.21 1.86 4.47 74,542
BERGEPAINT 490.05 1.03 4.45 8,367
MPHASIS 2,848.25 0.29 4.24 4,058
PIIND 4,456.85 2.05 4.16 1,235
Short Build Up
Nifty Outperformers Company Last % Chg % Chg OI OI (in 000)
Price % Chg % MTD % YTD MANAPPURAM 157.19 (0.04) 14.13 54,972
ZYDUSLIFE 964.15 (1.34) 8.93 14,018
Britannia Industries Ltd 5,047 0.4 (11.9) (5.5)
BRITANNIA 5,049.85 (0.21) 2.24 2,892
Ntpc Ltd 381 0.3 (6.6) 22.6
TATAMOTORS 788.70 (0.12) 0.92 99,548
Tata Motors Ltd 786 0.2 (5.7) 1.1
GODREJCP 1,185.20 (0.70) 0.12 11,623
Hindustan Unilever Ltd 2,465 0.1 (2.1) (7.1)
Infosys Ltd 1,868 (0.0) 6.3 21.8 Short Covering
Itc Ltd 472 (0.1) (3.4) 2.2 Company Last % Chg % Chg OI OI (in 000)
Asian Paints Ltd 2,471 (0.2) (15.8) (27.4) MARICO 598.30 (0.09) (2.36) 20,618
ALKEM 5,577.65 (1.62) (1.66) 1,750
Nifty Underperformers HINDUNILVR 2,467.25 (0.09) (1.48) 16,212
Price % Chg % MTD % YTD HAVELLS 1,618.80 (0.64) (0.15) 10,356
Hero Motocorp Ltd 4,520 (4.3) (9.4) 9.8 Long Unwinding
Hindalco Industries Ltd 627 (3.8) (8.7) 1.9 Company Last % Chg % Chg OI OI (in 000)
Tata Steel Ltd 139 (3.5) (6.3) (0.3) GNFC 545.95 7.94 (26.60) 8,084
Mahindra & Mahindra Ltd 2,799 (3.4) 2.6 61.8 IPCALAB 1,500.00 3.34 (13.86) 2,129
Eicher Motors Ltd 4,589 (3.2) (6.3) 10.7 DEEPAKNTR 2,479.35 3.00 (13.84) 2,367
Adani Ports And Special Econ 1,288 (2.9) (6.4) 25.7 METROPOLIS 2,056.45 6.12 (8.14) 1,120
Bajaj Auto Ltd 9,452 (2.3) (3.9) 39.1 SUNTV 707.55 0.69 (6.90) 5,869
Bulk Deals
Security Name Client Name Buy/Sell Qty Price Value (mn)
TIRTPLS Forbes EMF Buy 8,00,000 203.00 162
TIRTPLS Mitcon Sun Power Limited Sell 7,99,271 203.00 162
TIRTPLS Azura Projects Private Limited Sell 9,25,000 145.65 135
TIRTPLS Genesis Grand General Trading L.L.C Buy 8,90,000 145.65 130
TIRTPLS Walery Security Management Limited Buy 10,17,268 98.40 100
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 3
30000 36 4.5
27000 4.0
24000 31
3.5
21000
26 3.0
18000
15000 2.5
21
12000 2.0
9000 16 1.5
Nov-20 Nov-21 Nov-22 Nov-23 Nov-24 Nov-20 Nov-21 Nov-22 Nov-23 Nov-24 Nov-20 Nov-21 Nov-22 Nov-23 Nov-24
Source: Bloomberg
Sensex FII Provisional Flows (INR bn) DII Provisional Flows (INR bn)
290 155
95000 130
230
85000 105
170 80
75000
65000 110 55
55000 50 30
5
45000 (10)
(20)
35000 (70) (45)
25000 (130) (70)
Nov-20 Nov-21 Nov-22 Nov-23 Nov-24 Nov-20 Nov-21 Nov-22 Nov-23 Nov-24 Nov-20 Nov-21 Nov-22 Nov-23 Nov-24
Source: Bloomberg
Source: Bloomberg
Nov-23
Aug-24
Nov-24
Feb-23
May-23
Feb-24
May-24
10
07-Nov
08-Nov
11-Nov
12-Nov
13-Nov
4-Oct
5-Aug
15-Aug
25-Aug
4-Sep
14-Sep
24-Sep
3-Nov
13-Nov
26-Jul
14-Oct
24-Oct
Source: Bloomberg
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 4
Financials
Profit and loss account (INR mn) Key assumptions
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 31,466 33,279 34,918 39,270 43,446 Gross margin (%) 37.3 37.0 40.0 40.3 40.5
Gross Profit 11,726 12,299 13,967 15,826 17,595 Employee expenses (%) 5.9 5.3 5.3 5.1 4.9
Op. Expenses (29,616) (30,857) (31,208) (34,763) (38,248) Ad-spends (% of sales) 4.6 4.7 4.5 4.5 4.5
EBITDA 1,850 2,421 3,710 4,507 5,198
Depreciation (551) (579) (679) (833) (978) Cash flow statement (INR mn)
EBIT 1,298 1,843 3,031 3,674 4,220 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Other income 111 63 50 70 100 PBT 59 178 1,994 2,870 3,592
Interest Exp. (1,350) (1,728) (1,087) (874) (728) Depreciation & amortization 551 579 679 833 978
Reported PBT 59 178 1,994 2,870 3,592 Interest expense 1,350 1,728 1,087 874 728
Tax (43) (110) (498) (717) (898) (Inc)/Dec in working capital 327 (655) (5,472) 214 1,210
Reported PAT 16 68 1,495 2,152 2,694 Tax paid (40) (110) (498) (717) (898)
Net Profit 16 68 1,495 2,152 2,694 CF from operating activities 2,299 1,857 (2,210) 4,073 5,610
Adjusted PAT 16 18 1,495 2,152 2,694 Capital expenditure (195) (446) (2,500) (2,800) (2,200)
Adjusted EPS (INR) 0.1 0.1 5.3 7.7 9.6 Inc/(Dec) in investments (10) (122) - - -
Add: Interest/Div. Income Recd. 22 23 - - -
Balance sheet (INR mn) CF from investing activities (184) (545) (2,500) (2,800) (2,200)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Inc/(Dec) in share capital - (10) 9,071 - -
Share Capital 488 488 559 559 559 Inc/(Dec) in debt (557) 421 (958) - -
Reserves & Surplus 3,573 3,581 13,329 14,405 15,752 Dividend Paid - - (748) (1,076) (1,347)
Networth 4,061 4,069 13,888 14,964 16,311 Others (1,212) (1,501) (1,087) (874) (728)
Debt 7,762 8,241 7,283 7,283 7,283 CF from financing activities (1,768) (1,090) 6,279 (1,950) (2,075)
Net deferred Tax liabilities (121) (98) (98) (98) (98) Net cash flow 346 222 1,568 (677) 1,335
Capital Employed 11,702 12,213 21,073 22,150 23,497 Opening balance 184 530 753 2,321 1,644
Gross Fixed Assets 10,627 11,686 14,186 16,986 19,186 Closing balance 530 753 2,321 1,644 2,979
Accumulated Depreciation (4,911) (5,379) (6,058) (6,891) (7,869)
Capital work in progress 140 159 159 159 159 Growth indicators (%)
Net Fixed Assets 5,856 6,466 8,287 10,254 11,476 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Goodwill 39 39 39 39 39 Revenue 17.2 5.8 4.9 12.5 10.6
Current Assets, Loans & Adv. 18,861 19,754 25,619 25,740 26,700 EBITDA (6.3) 30.9 53.2 21.5 15.3
Inventory 5,592 4,188 5,166 5,138 5,666 Adj PAT (73.0) 14.3 NA 43.9 25.2
Debtors 9,576 12,437 16,619 17,444 16,542 Adj EPS (74.0) 14.3 NA 43.9 25.2
Cash & Bank balance 530 753 2,321 1,644 2,979
Loans & advances and others 3,163 2,376 1,513 1,513 1,513
Valuation (x)
Current Liabilities & Provisions 13,053 14,046 12,871 13,883 14,718
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
P/E (x) NA NA 57.6 40.0 32.0
Liabilities 12,697 13,686 12,511 13,523 14,358
P/BV (x) 18.5 18.5 6.2 5.8 5.3
Provisions 357 360 360 360 360
EV/EBITDA (x) 50.5 38.7 24.6 20.4 17.4
Net Current Assets 5,807 5,708 12,748 11,857 11,982
EV/Sales (x) 3.0 2.8 2.6 2.3 2.1
Application of Funds 11,702 12,213 21,073 22,150 23,497
Dividend Yield (%) - - 0.9 1.2 1.6
Per share data
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Financial ratios
No. of shares (mn) 244 244 280 280 280
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 0.4 0.4 16.7 14.9 17.2
Diluted no. of shares (mn) 244 244 280 280 280
RoCE (%) 11.7 15.9 18.5 17.3 18.9
BVPS (INR) 16.6 16.7 49.7 53.5 58.3
Asset/T.O (x) 2.7 2.8 2.1 1.8 1.9
CEPS (INR) 2.3 2.6 7.8 10.7 13.1
Net Debt/Equity (x) 1.8 1.8 0.4 0.4 0.3
DPS (INR) - - 2.7 3.8 4.8
EBIT/Interest (x) (1.0) (1.1) (2.8) (4.3) (5.9)
Source: Company, Antique
Margins (%)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
EBITDA Margin (%) 5.9 7.3 10.6 11.5 12.0
EBIT Margin (%) 4.1 5.5 8.7 9.4 9.7
PAT Margin (%) 0.1 0.1 4.3 5.5 6.2
Source: Company Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 6
Operating metrics 2QFY25 2QFY24 YoY (%) 1QFY25 QoQ (%) 1HFY25 CPLY (1HFY24) YoY (%)
Iron ore despatches (MT) 9.7 9.6 1.8 10.1 (3.3) 19.8 20.5 (3.6)
Iron ore realization (INR per ton) 4,876 4,176 16.8 5,334 (8.6) 5,105 4,513 13.1
EBITDA (INR per ton) 1,479 1,247 18.6 2,344 (36.9) 1,911 1,533 24.7
Source: Company, Antique
12.0 7,000
6,000
10.0
5,000
8.0
4,000
6.0
3,000
4.0 2,000
2.0 1,000
- 0
Q2FY23
Q3FY23
Q4FY23
Q1FY24
Q2FY24
Q3FY24
Q4FY24
Q1FY25
Q2FY25
2QFY18
3QFY18
4QFY18
1QFY19
2QFY19
3QFY19
4QFY19
1QFY20
2QFY20
3QFY20
4QFY20
1QFY21
2QFY21
3QFY21
4QFY21
1QFY22
2QFY22
3QFY22
4QFY22
1QFY23
2QFY23
3QFY23
4QFY23
1QFY24
2QFY24
3QFY24
4QFY24
1QFY25
2QFY25
2QFY18
3QFY18
4QFY18
1QFY19
2QFY19
3QFY19
4QFY19
1QFY20
2QFY20
3QFY20
4QFY20
1QFY21
2QFY21
3QFY21
4QFY21
1QFY22
2QFY22
3QFY22
4QFY22
1QFY23
Financials
Profit and loss account (INR bn) Cash flow statement (INR bn)
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Revenues 177 213 228 270 291 PBT 64 83 92 112 123
Expenses 116 139 145 169 180 Depreciation 3 3 4 4 5
EBITDA 61 74 82 101 110 Interest 1 1 1 1 1
Depreciation & amortization 3 3 4 4 5 (Inc)/ Dec in working capital (46) 24 13 (16) (11)
EBIT 57 70 79 97 105 Tax paid (21) (24) (23) (29) (31)
Other income 7 14 14 16 18 CF from operating activities 1 87 86 72 86
Interest expense 1 1 1 1 1 Capex (12) (12) (23) (23) (25)
Profit before tax 64 83 92 112 123 (Inc)/ Dec in Investments 1 (1) - - -
Extraordinaries 12 (3) - - - Income from investments 12 (3) - - -
Tax 21 24 23 29 31 CF from investing activities 2 (16) (23) (23) (25)
Profit after tax 55 56 68 84 92 Inc/ (Dec) in debt 3 12 (17) (2) -
Adjusted PAT 43 59 68 84 92 Dividends & Interest paid (19) (21) (28) (29) (32)
EPS (INR) 14.6 20.2 23.4 28.6 31.3 Others 5 (10) (1) (1) (1)
CF from financing activities (11) (19) (45) (32) (33)
Balance sheet (INR bn) Net cash flow (9) 52 18 17 28
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e Add: Opening balance 79 70 123 140 157
Share Capital 3 3 3 3 3 Closing balance 70 123 140 157 185
Reserves & Surplus 220 251 292 346 406
Networth 223 254 295 349 408 Growth indicators (%)
Debt 21 34 17 15 15 Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Deferred tax/ other liabilities (3) (3) (3) (3) (3) Revenue (32.0) 20.5 6.9 18.9 7.5
Capital Employed 242 285 309 361 421 EBITDA (52.0) 21.3 11.9 23.0 9.0
Net Assets 30 32 38 44 49
Valuation
Capital work in progress 20 32 45 58 73
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Investments 9 10 10 10 10
P/E (x) 15.2 11.0 9.6 7.8 7.1
Current Assets Loans & Advances
P/BV (x) 2.9 2.6 2.2 1.9 1.6
Inventory 27 27 17 19 20
EV/EBITDA (x) 10.0 7.7 6.4 5.0 4.4
Debtors 44 35 32 41 48
EV/Sales (x) 3.4 2.7 2.3 1.9 1.7
Cash & Bank 70 123 140 157 185
Dividend Yield (%) 3.0 3.3 4.3 4.5 4.9
Loans & advances and others 94 92 94 111 120
Current Liabilities & Provisions
Financial ratios
Creditors 38 49 50 59 63
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Provisions 14 17 17 20 22
RoE 21.3 24.8 24.9 26.0 24.2
Net Current Assets 183 211 216 249 288
RoCE 26.4 29.5 34.8 38.2 35.3
Application of Funds 242 285 309 361 421
Debt/Equity (x) (0.2) (0.4) (0.4) (0.4) (0.4)
13
16
3
2
-1
-3
-5
29,358 -12
30,409
29,026
29,677
34,402
33,239
30,318
34,147
3QFY23 4QFY23 1QFY24 2QFY24 3QFY24 4QFY24 1QFY25 2QFY25
Revenue QoQ growth %
Source: Company, Antique
US
17%
India
73%
22
22
3
1
-4
19,724 -12
-5
19,922 -10
20,113
19,007
23,278
22,328
20,233
24,610
3QFY23 4QFY23 1QFY24 2QFY24 3QFY24 4QFY24 1QFY25 2QFY25
India QoQ growth %
Source: Company, Antique
18
10
-7
-9
-11
5,916 -22
7,612
6,955
7,675
6,838
6,241
6,416
5,940
3QFY23 4QFY23 1QFY24 2QFY24 3QFY24 4QFY24 1QFY25 2QFY25
US QoQ growth %
Source: Company, Antique
22.0
21.7
21.3
13.7
13.1
12.2
5,991
3,533
3,892
7,467
7,076
4,020
6,086
7,528
20.2
19.6
19.3
18.0
15.0
10.4
9.7
5.5
4,547
1,585
2,867
6,755
6,422
3,042
5,452
6,886
3QFY23 4QFY23 1QFY24 2QFY24 3QFY24 4QFY24 1QFY25 2QFY25
PAT margins %
Source: Company, Antique
6.0
5.1
4.3
4.3
4.2
4.1
4.1
3.4
3.3
1,305
1,297
1,472
1,202
1,158
1,111
1,757
1,257
1,465
2QFY23 3QFY23 4QFY23 1QFY24 2QFY24 3QFY24 4QFY24 1QFY25 2QFY25
R&D spend as % sales
Source: Company, Antique
7%
7%
5%
1,04,551
80,011
84,337
90,943
97,465
7%
6%
0%
347 -1%
331 -1%
312
334
351
FY23 FY24 FY25E FY26E FY27E
US revenue (USD mn) YoY growth (%)
Source: Company, Antique
17.7%
21.9%
20.7%
20.7%
13.9%
16,095
22,455
27,578
29,722
33,136
FY23 FY24 FY25E FY26E FY27E
EBITDA (INR mn) EBITDA Margin (%)
Source: Company, Antique
17.4%
16.8%
17.4%
9.2%
10,654
19,052
23,221
24,869
25,378
n As of September 30, 2024, the company had filed 178 ANDAs and two new drug
applications (NDAs) with the USFDA. Of the filed ANDAs, 152 approvals (including 14
tentative) have been received till date. Till date the company has commercialized only
~100 products.
n Back orders down to 2% now vs. 38% at the start of the issue.
n One launch expected in 3Q where the company has 180 days exclusivity.
n Expect flattish revenue for FY25.
n Profitability has improved in the US, driven by discontinuing of unviable products and
cost optimization. Expect further improvement driven by improved launch.
n EBITDA margin in the US was lower than the company average.
n The company has received approval for Sacubitril + Valsartan but awaits litigation outcome
between Novartis and one generic player.
n ALKEM will be launching Mirabegron after FY26.
Other international markets
n Other international markets recorded ~13% YoY growth to INR 3.2 bn, accounting for
~10% of revenue.
n ROW market growth to be driven new launches and expansion of markets.
n Management remains bullish on the ROW business in the medium term.
Enzene biosciences
n Enzene biosciences’s US plant continues to progress as per plan and expects
commercialization in 1HCY25.
n The US unit would be focusing on pre-clinical to clinical opportunities.
n INR 4.5 bn has been spent on the unit so far.
n Expects the unit to EBITDA breakeven in a year of operation.
n 7-8 biosimilar products launched in India.
n Completed Denosumab clinical trials for the US market.
n Has commercialized seven products in India.
MedTech
n The company announced a tie-up with US-based Exactech to manufacture and to market
the latter’s joint replacement implants in India.
n Expect product launch in 1HFY26.
n The technical knowhow transfer for hip and knee implants from Exactech to ALKEM
remains as per plans.
n Brand transfers to Alkem MedTech has already began.
Guidance
n Revenue growth guidance revised downwards to mid-single digit in FY25.
n Gross margin for the fiscal to see an improvement of ~150 bps in FY25.
n R&D spends will be around 4.5%-5% for the fiscal.
n Margin guidance has been increased to ~18.5%-19% for FY25 from ~18%. Medtech
and Enzene related expects to be ~INR 600 mn for 2HFY25.
n Expect ~100 bps margin improvement annually post FY25.
n ETR guided at ~11%-13% for FY25.
n The company is exploring M&A opportunities and hence there is an increase in non-
current liquid deposits. Only INR 130 mn of strategic investments are reflected in non-
current assets.
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 20
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 1,15,993 1,26,676 1,33,475 1,43,255 1,51,223 PBT 13,048 20,231 26,871 28,752 31,904
Op. Expenses 99,898 1,04,221 1,05,897 1,13,534 1,18,087 Depreciation & amortization 3,104 2,993 3,363 3,626 3,888
EBITDA 16,095 22,455 27,578 29,722 33,136 Interest expense 1,074 1,124 1,844 1,844 1,844
Depreciation 3,104 2,993 3,363 3,626 3,888 (Inc)/Dec in working capital 3,268 (517) (8,358) (3,547) (2,890)
EBIT 12,990 19,462 24,215 26,096 29,248 Tax paid (2,734) (4,069) (3,493) (3,738) (6,381)
Other income 2,161 3,108 4,500 4,500 4,500 Less: Interest/Div. Income Recd. (1,711) (2,758) - - -
Interest Exp. 1,074 1,124 1,844 1,844 1,844 Other operating Cash Flow 776 2,476 - - -
Extra Ordinary Items -gain/(loss) (1,030) (1,215) - - - CF from operating activities 16,824 19,481 20,227 26,937 28,366
Reported PBT 13,048 20,231 26,871 28,752 31,904 Capital expenditure (2,297) (1,868) (5,000) (5,000) (5,000)
Tax 2,980 2,117 3,493 3,738 6,381 Inc/(Dec) in investments 1,993 (18,933) - - -
Reported PAT 10,068 18,114 23,378 25,014 25,523 Add: Interest/Div. Income Recd. 1,471 2,395 - - -
Minority Int./Profit (loss) From Asso. (226) (157) (157) (145) (145) CF from investing activities 1,167 (18,406) (5,000) (5,000) (5,000)
Net Profit 9,842 17,957 23,221 24,869 25,378 Inc/(Dec) in share capital 1,615 - - - -
Adjusted PAT 10,654 19,052 23,221 24,869 25,378 Inc/(Dec) in debt (12,785) (4,809) - - -
Adjusted EPS (INR) 89.1 159.3 194.2 208.0 212.3 Dividend Paid (5,295) (5,405) (7,173) (7,173) (7,173)
Others (1,143) (1,236) (1,844) (1,844) (1,844)
Balance sheet (INR mn) CF from financing activities (17,608) (11,450) (9,017) (9,017) (9,017)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Net cash flow 383 (10,375) 6,210 12,920 14,349
Share Capital 239 239 239 239 239 Opening balance 25,786 26,169 15,794 22,003 34,923
Reserves & Surplus 90,214 1,02,882 1,18,929 1,36,625 1,54,830 Closing balance 26,169 15,794 22,003 34,923 49,272
Networth 90,453 1,03,121 1,19,168 1,36,864 1,55,069
Debt 13,967 14,184 14,184 14,184 14,184 Growth indicators (%)
Minority Interest 3,897 4,023 4,180 4,325 4,470 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net deferred Tax liabilities (13,025) (15,148) (15,148) (15,148) (15,148) Revenue (%) 9.1 9.2 5.4 7.3 5.6
Capital Employed 95,292 1,06,180 1,22,384 1,40,226 1,58,575 EBITDA (%) (21.6) 39.5 22.8 7.8 11.5
Gross Fixed Assets 36,371 41,270 44,770 48,270 51,770 Adj PAT(%) (35.8) 78.8 21.9 7.1 2.0
Accumulated Depreciation 13,674 16,709 20,073 23,699 27,587 Adj EPS(%) (35.8) 78.8 21.9 7.1 2.0
Capital work in progress 3,232 1,586 3,086 4,586 6,086
Net Fixed Assets 25,929 26,146 27,783 29,157 30,268 Valuation (x)
Goodwill 4,132 4,167 4,167 4,167 4,167 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Investments 6,218 34,140 34,140 34,140 34,140 P/E (x) 62.6 35.0 28.7 26.8 26.3
Non Current Investments 3,046 3,348 3,348 3,348 3,348 P/BV (x) 7.4 6.5 5.6 4.9 4.3
Current Investments 3,172 30,792 30,792 30,792 30,792 EV/EBITDA (x) 40.5 28.2 22.8 20.7 18.1
Current Assets, Loans & Adv. 88,262 76,147 86,765 1,04,223 1,22,269 EV/Sales (x) 5.6 5.0 4.7 4.3 4.0
Inventory 26,075 26,612 27,061 29,044 30,659 Dividend Yield (%) 0.9 0.7 1.1 1.1 1.1
Debtors 21,322 22,528 24,867 26,689 28,173
Cash & Bank balance 26,169 15,794 22,003 34,923 49,272
Financial ratios
Loans & advances and others 14,696 11,214 12,834 13,568 14,165
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 12.0 19.7 20.9 19.4 17.4
Current Liabilities & Provisions 29,250 34,421 30,470 31,461 32,269
RoCE (%) 15.4 22.4 25.1 23.3 22.6
Liabilities 21,829 30,154 26,203 27,194 28,002
Asset/T.O (x) 1.3 1.7 1.8 1.5 1.4
Provisions 7,421 4,267 4,267 4,267 4,267
Net Debt/Equity (x) (0.2) (0.3) (0.3) (0.4) (0.4)
Net Current Assets 59,013 41,726 56,294 72,762 90,000
EBIT/Interest (x) 14.1 20.1 15.6 16.6 18.3
Application of Funds 95,292 1,06,180 1,22,384 1,40,226 1,58,575
PLF
Budge Budge 89% 93% (370) 90% (100) 90.0% 93.0% (300)
Southern 34% 76% na 81% NM 57.0% 81.0% (2,400)
Haldia 100% 95% 510 78% 2,200 89.0% 94.0% (500)
Dhariwal 92% 91% 120 94% (200) 93.0% 91.0% 200
Crescent Power 101% 101% - 77% 2,400 89.0% 91.0% (200)
Solar 21% 14% 670 22% (100) 20.0% 21.0% (100)
Standalone distribution loss 6.9% 7.3% (38)
Source: Company, Antique
Jul/19
Feb/20
Nov/14
Jun/15
Jan/16
Aug/16
Mar/17
Oct/17
Dec/18
Sep/20
Apr/21
Nov/21
Jun/22
Jan/23
Aug/23
Mar/24
Oct/24
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 1,42,460 1,52,930 1,71,506 1,82,653 1,93,613 PBT 17,391 16,830 19,615 21,763 24,735
Op. Expenses (1,20,970) (1,31,670) (1,37,456) (1,39,272) (1,48,362) Depreciation & amortization 10,804 12,170 12,371 12,563 12,852
EBITDA 21,490 21,260 34,049 43,382 45,251 Interest expense 11,170 12,340 11,910 12,027 11,577
Depreciation (8,780) (12,170) (12,371) (12,563) (12,852) (Inc)/Dec in working capital (895) (34,337) (678) (407) (400)
EBIT 12,710 9,090 21,678 30,818 32,399 Tax paid (14,393) 5,290 (2,751) (12) (12)
Other income 3,088 2,510 2,957 2,971 3,913 Other operating Cash Flow (4,293) 23,567 - - -
Interest Exp. (11,170) (12,340) (11,910) (12,027) (11,577) CF from operating activities 19,784 35,860 40,468 45,934 48,752
Regulatory Income (Expense) 12,760 17,570 6,890 - - Capital expenditure 9,179 (5,556) (5,220) (5,000) (7,500)
Reported PBT 17,388 16,830 19,615 21,763 24,735 chng in investments (11,002) (12,505) (6,890) - -
Tax (3,420) (2,360) (2,751) (3,052) (3,468) CF from investing activities (1,823) (18,060) (12,110) (5,000) (7,500)
Reported PAT 13,968 14,470 16,864 18,711 21,266 Inc/(Dec) in share capital - - - - -
Minority Int./Profit (loss) From Asso. 540 710 - - - Inc/(Dec) in debt 15,972 1,804 (5,000) (5,000) (5,000)
Net Profit 13,428 13,760 16,864 18,711 21,266 Dividend Paid (6,038) (6,038) (6,038) (6,038) (6,038)
Adjusted PAT 13,428 13,760 16,864 18,711 21,266 Others (34,506) (12,340) (11,910) (12,027) (11,577)
Adjusted EPS (INR) 10.1 10.4 12.7 14.1 16.0 CF from financing activities (24,572) (16,574) (22,948) (23,065) (22,615)
Net cash flow (6,611) 1,226 5,410 17,869 18,637
Balance sheet (INR mn) Opening balance 32,495 25,884 27,110 32,520 50,389
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Closing balance 25,884 27,110 32,520 50,389 69,027
Share Capital 1,332 1,332 1,332 1,332 1,332
Reserves & Surplus 1,07,772 1,13,120 1,17,057 1,32,769 1,51,455 Growth indicators (%)
Networth 1,09,104 1,14,452 1,18,389 1,34,102 1,52,787 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Debt 1,65,966 1,77,350 1,72,350 1,67,350 1,62,350 Revenue 13.6 7.3 12.1 6.5 6.0
Minority Interest 4,787 5,400 5,400 5,400 5,400 EBITDA incl deferral income -7.9 21.3 9.9 7.2 4.3
Net deferred Tax liabilities 28,410 41,250 41,250 41,250 41,250 Adj PAT -1.2 2.5 22.6 10.9 13.7
Capital Employed 3,08,267 3,38,452 3,37,389 3,48,102 3,61,787 Adj EPS -1.2 2.5 22.6 10.9 13.7
Gross Fixed Assets 3,10,886 3,16,106 3,21,326 3,26,326 3,33,826
Accumulated Depreciation (83,256) (95,426) (1,07,797) (1,20,360) (1,33,212) Valuation (x)
Capital work in progress 1,404 1,740 1,740 1,740 1,740 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Fixed Assets 2,29,034 2,22,420 2,15,269 2,07,705 2,02,353 P/E (x) 17.3 16.9 13.8 12.4 10.9
Investments 82,104 83,340 83,340 83,340 83,340 P/BV (x) 2.1 2.0 2.0 1.7 1.5
Non Current Investments 82,104 83,340 83,340 83,340 83,340 EV/EBITDA (x) 17.3 18.0 10.9 8.0 7.2
Current Assets, Loans & Adv. 70,472 65,650 75,741 96,420 1,17,819 EV/Sales (x) 2.6 2.5 2.2 1.9 1.7
Inventory 8,802 8,780 9,846 10,486 11,116 Dividend Yield (%) 2.6 2.6 2.6 2.6 2.6
Debtors 21,915 22,580 25,323 26,969 28,587
Cash & Bank balance 25,884 27,110 32,520 50,389 69,027
Financial ratios
Loans & advances and others 13,871 7,180 8,052 8,575 9,090
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 1.1 -2.8 8.6 17.2 17.2
Current Liabilities & Provisions 73,344 32,958 36,961 39,364 41,726
RoCE (%) 4.7 3.2 7.3 12.0 12.0
Liabilities 71,964 32,360 36,291 38,649 40,968
Asset/T.O (x) 0.4 0.4 0.5 0.6 0.6
Provisions 1,380 598 671 714 757
Net Debt/Equity (x) 1.1 1.0 0.9 1.0 0.8
Net Current Assets (2,872) 32,692 38,780 57,056 76,094
EBIT/Interest (x) 1.4 0.9 2.1 2.8 3.1
Application of Funds 3,08,267 3,38,452 3,37,389 3,48,102 3,61,787
Shareholding pattern Ambitious aim to reach USD 2 bn by FY30 led by multiple initiatives
KOEL has strategically restructured its business reinforcing group values & cultivating a strong
Promoters : 41%
culture has helped it not only to prepare for 2X-3Y journey but also look out for a farfetched
Public : 59% horizon to reach USD 2 bn by FY30. The company believes that it can be achieved by its core
Others : 0% manufacturing strategy, make versus buy decision, efficient sourcing & machining strategies,
Source: Bloomberg and enhancing capacity levels. For the B2C segment, a new plant has been commissioned
during 2QFY25 & KOEL believes that the new plant should be help the company achieve
Price performance vs Nifty
productivity and efficiency and also help it deliver better profitability for the industrial portfolio.
270
Investment Summary
210
KOEL’s earnings have remained flat over FY17–22, impacted by weak end-consumer demand.
150 However, moving ahead, multiple demand drivers are evident: a) Strong demand from real
90 estate, b) Intent to scale up manufacturing contribution from 15% to 25%, and c) The CPCB
Nov-23 Mar-24 Jul-24 Nov-24 IV+ compliant product portfolio, which we believe will help the company register 26% earnings
Kirloskar Oil NIFTY CAGR over FY24–27E. We retain BUY rating on the stock with a revised SoTP TP of INR 1,550
Source: Bloomberg Indexed to 100 (earlier INR 1,591), valuing the core business at 28x its FY27E EPS.
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 27
17%
1QFY19 814 9.9 2QFY19 480 6.3
2QFY19 658 8.6 560 7.3
22%
3QFY19 663 8.6 4QFY19 580 7.3
margin at 12.4%
4QFY19 860 10.8
Story in Charts
11%
1QFY20 734 9.6 2QFY20 690 10.2
2QFY20 436 6.4 600 8.4
0%
10%
740 11.3
1QFY21 -45 (1.4)
International
-
2
4
6
8
Water Management
Farm Mechanization
10
12
14
16
2QFY25 1,650 13.8
1QFY18 365 (38.0) 1QFY18 7.09 6.7
25
30
35
40
45
50
2QFY18 299 (29.8) 2QFY18 6.47 (2.5)
3QFY18 395 40.8 1QFY18 35.3 3QFY18 6.85 6.8
4Q FY18 443 0.2 2QFY18 36.0 4Q FY18 7.91 13.0
1QFY19 496 36.2 3QFY18 36.8 1QFY19 8.20 15.6
2QFY19 412 37.9 4Q FY18 35.4 2QFY19 7.62 17.8
3QFY19 420 6.3 1QFY19 32.8 3QFY19 7.74 13.1
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 41,161 48,505 55,276 64,655 75,982 PBT 3,641 4,868 5,919 7,712 9,619
Op. Expenses 36,892 42,864 48,426 55,955 65,327 Depreciation & amortization 848 970 1,132 1,193 1,245
Gross Profit 13,264 16,066 18,517 21,983 25,834 Interest expense 54 78 87 98 109
EBITDA 4,269 5,642 6,850 8,700 10,655 (Inc)/Dec in working capital (1,025) (441) (625) (505) (610)
Depreciation 848 970 1,132 1,193 1,245 Tax paid (960) (1,084) (1,492) (1,944) (2,424)
EBIT 3,422 4,672 5,718 7,507 9,410 CF from operating activities 2,601 4,339 5,021 6,554 7,940
Other income 273 274 288 303 318 Capital expenditure (1,213) (2,765) (1,248) (1,248) (1,248)
Interest Exp. 54 78 87 98 109 Inc/(Dec) in investments (54) (1,660) (261) - -
Reported PBT 3,641 4,868 5,919 7,712 9,619 CF from investing activities (1,556) (4,182) (1,581) (1,147) (1,107)
Tax 939 1,252 1,492 1,944 2,424 Inc/(Dec) in debt (968) (751) (100) (100) (100)
Reported PAT 2,703 3,616 4,427 5,769 7,195 Dividend Paid (723) (724) (1,328) (1,731) (2,158)
Net Profit 2,703 3,616 4,427 5,769 7,195 CF from financing activities (1,009) 500 (1,515) (1,928) (2,368)
Adjusted PAT 2,703 3,616 4,427 5,769 7,195 Net cash flow 35 657 1,925 3,479 4,465
Adjusted EPS (INR) 18.6 24.9 30.5 39.8 49.6 Opening balance 203 239 896 2,821 6,300
Closing balance 239 896 2,821 6,300 10,765
Balance sheet (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Growth indicators (%)
Share Capital 290 290 290 290 290 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Reserves & Surplus 23,029 25,937 29,036 33,074 38,111 Revenue 24.7 17.8 14.0 17.0 17.5
Networth 23,318 26,227 29,326 33,364 38,401 EBITDA 58.9 32.1 21.4 27.0 22.5
Debt 751 2,091 1,991 1,891 1,791 Adj PAT 87.2 33.8 22.4 30.3 24.7
Net deferred Tax liabilities 61 100 100 100 100 Adj EPS 87.2 33.8 22.4 30.3 24.7
Capital Employed 24,131 28,418 31,417 35,355 40,291
Gross Fixed Assets 15,822 16,722 17,622 18,522 19,422 Valuation (x)
Accumulated Depreciation 11,800 12,388 13,009 13,663 14,349 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Capital work in progress 664 2,426 2,426 2,426 2,426 P/E (x) 58.8 43.9 35.9 27.5 22.1
Net Fixed Assets 4,447 6,507 7,167 7,413 7,627 P/BV (x) 6.8 6.0 5.4 4.8 4.1
Goodwill 469 827 827 827 827 EV/EBITDA (x) 36.6 27.6 22.4 17.3 13.7
Investments 16,925 18,762 18,762 18,762 18,762 EV/Sales (x) 379.9 321.2 278.2 232.3 191.7
Non Current Investments 14,309 14,879 14,879 14,879 14,879 Dividend Yield (%) 0.5 0.7 0.8 1.1 1.4
Current Investments 2,617 3,883 3,883 3,883 3,883
Current Assets, Loans & Adv. 11,557 13,115 16,240 21,892 28,982
Financial ratios
Inventory 4,685 5,235 5,966 6,978 8,201
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 12.1 14.6 15.9 18.4 20.1
Debtors 4,672 5,684 6,058 7,085 8,327
RoCE (%) 15.8 18.8 20.1 23.4 25.7
Cash & Bank balance 239 896 2,821 6,300 10,765
Asset/T.O (x) 7.2 6.2 5.4 4.7 4.2
Loans & advances and others 1,962 1,299 1,395 1,528 1,689
Net Debt/Equity (x) 0.0 0.1 0.1 0.1 0.0
Current Liabilities & Provisions 9,267 10,793 11,579 13,539 15,907
EBIT/Interest (x) 68.9 63.6 68.9 80.0 89.0
Liabilities 8,026 9,497 10,102 11,811 13,876
Provisions 1,241 1,296 1,477 1,728 2,030
Margins (%)
Net Current Assets 2,291 2,322 4,661 8,353 13,075
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Application of Funds 24,131 28,418 31,417 35,355 40,291
EBITDA Margin (%) 10.4 11.6 12.4 13.5 14.0
Per share data EBIT Margin 8.3 9.6 10.3 11.6 12.4
PAT Margin 6.6 7.5 8.0 8.9 9.5
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
No. of shares (mn) 145 145 145 145 145 Source: Company Antique
n Capex
l Capex will be spent for upgradation of sanitaryware and faucetware facilities.
l Planned capex for FY25 - INR 250 mn.
l Already expended in 1HFY25 - INR 110 mn.
n Sanitaryware greenfield expansion
l Land acquisition for greenfield expansion in sanitaryware segment has been
completed for INR 250-300 mn. The new project is expected to be completed within
18 months of commencement. This expansion is not expected to start in FY25.
l This capex is planned in two phases. Additional capacity in phase 1 would be 1.2
mn cases p.a. Capex would be INR 1.3 bn (including land acquisition cost). Expected
revenue from phase 1 to be INR 3 bn.
n Advertising costs: 2QFY25 - INR 160 mn. The spends are expected to bring traction
to its products in Tier 2 & 3 cities.
n Loyalty program: The company has enrolled 21,700 retailers. Recorded 3,60,000
invoices. Out of a total retail sales amounting to INR 2.97 bn, 39% are eligible for loyalty
rewards.
n Buyback of shares: The company completed buyback of shares amounting to INR
1.30 bn. Purchased 1,08,333 shares at INR 12,000 per share with the intent of returning
surplus cash back to the shareholders.
n Working capital: Inventory days increased from 73 days to 80 days. Receivable days
increased from 29 to 33 days. Payable days decreased from 42 to 41 days. Net working
capital days increased from 60 to 72 days.
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 37
Gross margin (%) 55.8 54.5 53.4 54.8 52.8 54.4 50.8 54.8 52.6 -24 bps -222 bps
EBITDA margin (%) 16.3 16.4 16.4 16.4 16.5 14.0 17.3 14.5 14.6 -188 bps 15 bps
EBITDA (INR mn) 679 750 872 704 765 614 950 581 721 (5.7) 24.2
2,000 20
15
Aug-19
Nov-19
Aug-20
Nov-20
Aug-21
Nov-21
Aug-22
Nov-22
Aug-23
Nov-23
Aug-24
Nov-24
Feb-19
May-19
Feb-20
May-20
Feb-21
May-21
Feb-22
May-22
Feb-23
May-23
Feb-24
May-24
0
Nov-12
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
Nov-18
Nov-19
Nov-20
Nov-21
Nov-22
Nov-23
Nov-24
May-12
May-13
May-14
May-15
May-16
May-17
May-18
May-19
May-20
May-21
May-22
May-23
May-24
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year-ended March 31 FY23 FY24 FY25e FY26e FY27e Year-ended March 31 FY23 FY24 FY25e FY26e FY27e
Net Revenue 18,035 18,794 19,391 21,510 23,882 PBT 2,849 3,188 2,489 2,991 3,499
Op. Expenses 15,105 15,761 16,441 18,047 19,825 Depreciation & amortization 326 365 391 407 500
EBITDA 2,930 3,033 2,950 3,463 4,057 Interest expense 31 56 70 65 58
Depreciation 326 365 391 407 500 (Inc)/Dec in working capital (770) 154 (28) (122) (235)
EBIT 2,604 2,667 2,559 3,056 3,557 Tax paid (727) (783) (705) (944) (1,091)
Other income 356 595 714 785 864 Less: Interest/Div. Income Received - (36) - - -
Interest Exp. 60 58 70 65 58 Other operating Cash Flow (85) (585) (23) (23) (23)
Extra Ordinary Items -gain/(loss) 38 12 - - - CF from operating activities 1,624 2,361 2,194 2,373 2,708
Reported PBT 2,861 3,192 3,203 3,777 4,363 Capital expenditure (383) (622) (510) (1,060) (510)
Tax 751 779 705 944 1,091 Inc/(Dec) in investments 373 581 - - -
Reported PAT 2,111 2,413 2,498 2,832 3,272 Add: Interest/Div. Income Received 29 37 714 785 864
Minority Int./Profit (loss) From Asso. (16) (23) (23) (23) (23) CF from investing activities 20 (4) 204 (275) 354
Net Profit 2,094 2,390 2,475 2,809 3,249 Inc/(Dec) in share capital - - (1,621) 0 0
Adjusted PAT 2,132 2,402 2,475 2,809 3,249 Inc/(Dec) in debt (13) (49) 74 (79) -
Adjusted EPS (INR) 161.0 183.8 191.9 217.8 251.9 Dividend Paid (457) (652) (903) (1,032) (1,161)
Others (126) (134) (70) (65) (58)
Balance sheet (INR mn) CF from financing activities (596) (835) (2,520) (1,176) (1,219)
Year-ended March 31 FY23 FY24 FY25e FY26e FY27e Net cash flow 1,048 1,521 (122) 923 1,843
Share Capital 65 65 64 64 64 Opening balance 5,421 6,607 8,142 8,020 8,943
Reserves & Surplus 11,661 13,393 13,344 15,122 17,210 Closing balance 6,468 8,129 8,020 8,943 10,786
Networth 11,726 13,458 13,409 15,186 17,275 Changes in other bank balances 139 13 - - -
Debt 253 205 279 200 200 Cash and cash equivalents 6,607 8,142 8,020 8,943 10,786
Minority Interest 106 128 128 128 128
Net deferred Tax liabilities 376 482 482 482 482 Growth indicators (%)
Capital Employed 12,462 14,272 14,297 15,996 18,084 Year-ended March 31 FY23 FY24 FY25e FY26e FY27e
Gross Fixed Assets 5,447 6,267 6,527 6,787 8,347 Revenue 24.7 4.2 3.2 10.9 11.0
Accumulated Depreciation 2,303 2,528 2,919 3,326 3,826 EBITDA 28.1 3.5 -2.7 17.4 17.2
Capital work in progress 420 130 380 1,180 130 Adj PAT 37.2 12.7 3.0 13.5 15.7
Net Fixed Assets 3,564 3,869 3,988 4,641 4,651 Adj EPS 38.6 14.1 4.4 13.5 15.7
Current Assets, Loans & Adv. 13,203 14,587 14,633 16,149 18,701
Inventory 3,825 3,636 3,705 4,066 4,515 Valuation (x)
Debtors 1,892 2,026 2,125 2,357 2,617 Year-ended March 31 FY23 FY24 FY25e FY26e FY27e
Cash & Bank balance 6,607 8,142 8,020 8,943 10,786 P/E (x) 42.1 36.8 35.3 31.1 26.9
Loans & advances and others 879 783 783 783 783 P/BV (x) 7.5 6.5 6.5 5.8 5.1
Current Liabilities & Provisions 4,304 4,183 4,324 4,794 5,267 EV/EBITDA (x) 27.9 26.4 27.2 22.9 19.1
Liabilities 2,069 1,790 1,853 2,033 2,257 EV/Sales (x) 4.5 4.3 4.1 3.7 3.2
Provisions 2,235 2,393 2,471 2,761 3,010 Dividend Yield (%) 0.7 0.9 1.0 1.2 1.3
Net Current Assets 8,898 10,404 10,310 11,355 13,434
Application of Funds 12,462 14,272 14,297 15,996 18,084
Financial ratios
Year-ended March 31 FY23 FY24 FY25e FY26e FY27e
Per share data RoE (%) 19.5 19.1 18.4 19.6 20.0
Year-ended March 31 FY23 FY24 FY25e FY26e FY27e RoCE (%) 25.3 24.4 22.9 25.4 25.9
No. of shares (mn) 13 13 13 13 13 Asset/T.O (x) 1.5 1.4 1.4 1.4 1.4
Diluted no. of shares (mn) 13 13 13 13 13 Net Debt/Equity (x) (0.5) (0.6) (0.6) (0.6) (0.6)
BVPS (INR) 901.6 1,034.8 1,039.6 1,177.5 1,339.4 EBIT/Interest (x) 48.9 56.0 46.8 59.1 76.2
CEPS (INR) 187.3 213.6 224.0 251.1 292.5
DPS (INR) 50.0 60.0 70.0 80.0 90.0
Margins (%)
Year-ended March 31 FY23 FY24 FY25e FY26e FY27e
Source: Company, Antique
EBITDA Margin (%) 16.2 16.1 15.2 16.1 17.0
EBIT Margin (%) 14.4 14.2 13.2 14.2 14.9
PAT Margin (%) 11.6 12.4 12.3 12.6 13.1
Source: Company Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 39
0
20
40
60
80
100
120
2QFY20
1QFY20 46
3QFY20
2QFY20 51
4QFY20 3QFY20 59
1QFY21 4QFY20 52
2QFY22 65
100
120
140
0
20
40
60
80
2QFY23 80
3QFY23 3QFY23 81
3QFY20
43
4QFY23 4QFY23 71
1QFY24 1QFY24 63
4QFY20
53
2QFY24 57
Q2FY24
3QFY24 50
66
1QFY21
44
EBITDA growth, yoy, %
1QFY25 49
1QFY25 2QFY25 44
Book to bill (years, RHS)
3QF21
54
2QFY25
0
1
1
2
2
3
3
4
4
4QFY21
82
66
0%
5%
10%
15%
20%
25%
100%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Q2FY22 1QFY18
45
18%
21% 1QFY20 21% 79%
3QFY22 3QFY18 23% 2QFY20 36% 64%
40
19% 3QFY20
1QFY19 20% 28% 72%
63
4QFY22 4QFY20 30% 70%
20%
FROM THE RESEARCH DESK
Irrigation
60
20%
1QFY20 19% 2QFY21 45% 55%
2QFY23
54
23% 3QFY21 45% 55%
3QFY20 22%
Exhibit 2: Order book trend
53
1QFY22 46% 54%
Exhibit 4: EBITDA margin trend
1QFY21 20%
4QFY23 21% 2QFY22 27% 73%
67
3QFY21 20%
19% 3QFY22 26% 74%
Roads
1QFY24
62
1QFY22 19% 4QFY22 25% 75%
22% 1QFY23 26% 74%
EBITDA Margin %
Q2FY24
65
3QFY22 21%
21% 2QFY23 24% 76%
3QFY24
61
1QFY23 19% 3QFY23 23% 77%
22% 4QFY23
3QFY23 19% 23% 77%
4QFY24
89
1QFY24
18%
3QFY24 16% 3QFY24 23% 77%
0
22%
19%
10
20
30
40
50
60
70
80
90
17%25%
100
Table 4: Snapshot
INR mn FY19 FY20 FY21 FY22 FY23 FY24 FY25E FY26E FY27E
Order Book 40,156 52,297 71,179 90,008 70,921 53,048 65,873 84,608 1,06,742
Order Inflow 38,263 34,583 45,908 51,555 18,351 23,037 50,000 60,000 70,000
Book to bill x 1.5 2.1 2.3 2.5 2.1 1.5 1.6 1.8 2.0
Revenue 21,373 22,442 27,026 32,726 37,438 40,910 37,175 41,264 47,867
Change yoy, % 11% 5% 20% 21% 14% 9% -9% 11% 16%
EBITDA 4,270 4,871 5,358 6,777 7,217 7,010 5,874 6,190 6,941
EBITDA Margin % 20.0 21.7 19.8 20.7 19.3 17.1 15.8 15.0 14.5
PAT 2,657 2,335 2,515 3,680 4,110 4,400 3,460 3,626 4,097
Change yoy, % -2.4 -12.1 7.7 46.3 11.7 7.0 -21.4 4.8 13.0
PAT Margin % 12.3 10.0 9.0 11.7 13.3 12.1 9.3 8.8 8.6
WC as a % of sales 13% 23% 33% 28% 43% 40% 38% 37% 34%
Net debt (INR bn) 2,252 1,821 -1,163 -1,669 -1,942 -2,346 -6,704 -7,425 -8,697
Net debt/ equity (x) 0.16 0.11 -0.06 -0.07 -0.07 -0.07 -0.19 -0.19 -0.20
Capex (INR bn) 2,034 2,036 939 2,939 516 728 500 1,000 1,000
CFO (INR.bn) 2,485 3,941 2,920 3,432 129 2,178 6,740 3,639 4,223
CFO/ EBITDA 58% 81% 55% 51% 2% 31% 115% 59% 61%
Source: Company, Antique
Table 5: SoTP-based TP
Particulars FY27E
PAT 4,097
Target Multiple (x) 18
Total Equity value 73,742
No of shares (mn) 281
EPC value per share (INR) 262
Value of BOT & HAM projects (INR/sh) 24
Target price (INR/sh) 286
Source: Company, Antique
Exhibit 6: PE band
25
20
15
10
0
May/18
Jul/19
Feb/20
Nov/14
Jun/15
Jan/16
Aug/16
Oct/17
Dec/18
Sep/20
Apr/21
Nov/21
Jun/22
Jan/23
Aug/23
Oct/24
Mar/17
Mar/24
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 37,438 40,910 37,175 41,264 47,867 PBT 7,413 7,103 4,932 5,211 5,909
Op. Expenses 30,221 33,900 31,301 35,075 40,926 Depreciation & amortization 1,474 1,245 1,292 1,346 1,418
EBITDA 7,217 7,010 5,874 6,190 6,941 Interest expense 393 293 102 150 190
Depreciation 1,474 1,245 1,292 1,346 1,418 (Inc)/Dec in working capital (6,625) (2,872) 2,236 (1,115) (1,096)
EBIT 5,743 5,765 4,582 4,844 5,523 Tax paid (2,117) (2,177) (1,370) (1,435) (1,622)
Other income 321 1,422 350 368 386 Less: Interest/Div. Income Recd. (17) (1,121) (350) (368) (386)
Interest Exp. 393 293 102 150 190 CF from operating activities 521 2,471 6,841 3,789 4,413
Extra Ordinary Items -gain/(loss) 1,380 - - - - Capital expenditure (516) (728) (500) (1,000) (1,000)
Reported PBT 7,051 6,893 4,830 5,061 5,719 Inc/(Dec) in investments 980 (1,950) (2,000) (2,000) (2,000)
Tax 2,062 1,955 1,370 1,435 1,622 Add: Interest/Div. Income Recd. 367 1,100 280 294 308
Reported PAT 4,988 4,938 3,460 3,626 4,097 CF from investing activities 830 (1,578) (2,220) (2,706) (2,692)
Net Profit 4,988 4,938 3,460 3,626 4,097 Inc/(Dec) in debt 3 (3) - - -
Adjusted PAT 4,110 4,400 3,460 3,626 4,097 Dividend Paid (70) (70) (59) (62) (70)
Adjusted EPS (INR) 14.6 15.6 12.3 12.9 14.6 Others (798) (472) (204) (300) (380)
CF from financing activities (866) (545) (263) (362) (450)
Balance sheet (INR mn) Net cash flow 486 348 4,358 721 1,271
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e Opening balance 1,513 1,998 2,346 6,704 7,425
Share capital 562 562 562 562 562 Closing balance 1,998 2,346 6,704 7,425 8,697
Reserves & Surplus 26,780 31,694 35,095 38,659 42,686
Networth 27,343 32,257 35,658 39,222 43,248 Growth indicators (%)
Other Non Current Liabilities 284 216 216 216 216 Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Capital Employed 27,627 32,472 35,873 39,437 43,464 Revenue 14.4 9.3 -9.1 11.0 16.0
Gross Fixed Assets 16,877 17,674 18,174 19,174 20,174 EBITDA 6.5 -2.9 -16.2 5.4 12.1
Accumulated Depreciation 12,724 13,969 15,260 16,606 18,024 Adj PAT 14.0 7.0 -21.4 4.8 13.0
Capital work in progress 25 22 22 22 22 Adj EPS 14.0 7.0 -21.4 4.8 13.0
Net Fixed Assets 4,179 3,728 2,936 2,590 2,172
Investments 2,633 7,283 9,283 11,283 13,283 Valuation (x)
Other Non Current Assets 2,817 2,783 2,853 2,927 3,004 Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Current Assets, Loans & Adv. 27,367 28,584 30,579 33,189 36,631 P/E (x) 21.1 19.7 25.0 23.9 21.1
Inventory 2,341 2,207 2,038 2,284 2,665 P/BV (x) 3.2 2.7 2.4 2.2 2.0
Debtors 9,834 13,642 12,397 13,001 13,114 EV/EBITDA (x) 11.7 12.0 13.6 12.8 11.2
Cash & Bank balance 1,998 2,346 6,704 7,425 8,697 EV/Sales (x) 2.3 2.1 2.1 1.9 1.6
Loans & advances and others 13,193 10,389 9,440 10,479 12,155 Dividend Yield (%) 0.1 0.1 0.1 0.1 0.1
Current Liabilities & Provisions 9,369 9,905 9,778 10,552 11,627
Liabilities 9,223 9,825 9,694 10,464 11,534
Financial ratios
Provisions 146 80 84 88 93
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 16.5 14.8 10.2 9.7 9.9
Net Current Assets 17,998 18,679 20,801 22,637 25,004
RoCE (%) 24.4 24.1 14.5 13.9 14.3
Application of Funds 27,627 32,472 35,873 39,437 43,464
Asset/T.O (x) 2.0 1.8 1.6 1.7 1.8
Per share data Net Debt/Equity (x) -0.07 -0.07 -0.19 -0.19 -0.20
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e EBIT/Interest (x) 15.4 24.5 48.4 34.7 31.1
No. of shares (mn) 281.2 281.2 281.2 281.2 281.2
Diluted no. of shares (mn) 281.2 281.2 281.2 281.2 281.2
Margins (%)
BVPS (INR) 97.2 114.7 126.8 139.5 153.8
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
EBITDA Margin (%) 19.3 17.1 15.8 15.0 14.5
CEPS (INR) 19.9 20.1 16.9 17.7 19.6
EBIT Margin 15.3 14.1 12.3 11.7 11.5
DPS (INR) 0.2 0.2 0.2 0.2 0.2
PAT Margin 11.0 10.8 9.3 8.8 8.6
Source: Company, Antique
Source: Company Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 45
0%
20%
40%
60%
80%
100%
1QFY20 5 1QFY19 53
2QFY20 5 1QFY19 49
3QFY20 6 2QFY19 3QFY19 43
3QFY19 62
4QFY20 6 1QFY20 57
4QFY19
1QFY21
Rajasthan
Story in Charts
Maharashtra
3QFY23 11 3QFY22 1QFY23 115
2QFY23 126
2QFY24 9 1QFY24 117
3QFY24 13 3QFY23 107
4QFY23 3QFY24 96
4QFY24 16
1QFY24 124
1QFY25 15
Haryana
2QFY24 1QFY25 156
2QFY25 11 3QFY24 166
0%
1QFY25
50%
-50%
100%
150%
200%
250%
0.50
1.00
1.50
2.00
2.50
3.00
3.50
-100%
2QFY25
-100%
-50%
0%
50%
100%
150%
200%
250%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0%
7% 4QFY19
4QFY20 1QFY22
FROM THE RESEARCH DESK
9%
EPC – Road
1QFY20
1QFY21-43%
-38% 2QFY20
-1% 2QFY22
2QFY21 5% 3QFY20
3QFY21 28% 3QFY22 4QFY20
34%
Revenue growth
4QFY21 65% 1QFY21
Government
67% 4QFY22
1QFY22 207% 2QFY21
206% 3QFY21
2QFY22 61% 1QFY23
63% 4QFY21
3QFY22 26% 2QFY23
HAM - Road
29% 1QFY22
4QFY22 0% 2QFY22
-7%
8%
2QFY23 0% 4QFY23 4QFY22
-4%
3QFY23 23% 1QFY23
24% 1QFY24 2QFY23
4QFY23 43%
52%
Railway
2QFY24 3QFY23
19%
Private
EBITDA growth
2QFY24 15% 3QFY24 1QFY24
Exhibit 4: Order book split between private and public
2QFY25 2QFY25
14 November 2024 | 48
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 49
16% 8.0
6.0
15%
4.0
1.6
10.3
11.2
14.0
14.7
14.3
13.6
10.5
13.9
15.2
15% 2.0
15%
15%
15%
16%
16%
16%
16%
16%
16%
17%
16%
15%
15%
16%
17%
16%
16%
16%
16%
16%
16%
16%
3.8
3.0
2.8
2.6
4.0
2.9
4.8
3.1
5.6
2.7
6.5
3.1
7.4
3.1
8.7
4.5
9.6
3.9
4.7
5.0
6.7
6.0
4.7
4.5
6.2
8.8
0.0
14%
1QFY21
2QFY21
3QFY21
4QFY21
1QFY22
2QFY22
Q3FY22
Q4FY22
1QFY24
2QFY24
3QFY24
4QFY24
1QFY23
2QFY23
3QFY23
4QFY23
1QFY25
2QFY25
1QFY20
2QFY20
3QFY20
4QFY20
1QFY21
2QFY21
3QFY21
4QFY21
1QFY22
2QFY22
3QFY22
4QFY22
1QFY23
2QFY23
3QFY23
4QFY23
1QFY24
2QFY24
3QFY24
4QFY24
1QFY25
2QFY25
EBITDA margin Standalone Debt (INR bn) Project Debt (INR bn)
Source: Company, Antique Source: Company, Antique
Table 6: Snapshot
INR mn FY21 FY22 FY23 FY24 FY25E FY26E FY27E
Order Book 70,400 79,729 1,25,953 1,24,340 1,74,657 2,24,794 2,72,295
Order Inflow 21,849 45,481 90,409 49,604 1,10,000 1,20,000 1,30,000
Book to bill x 2.8 2.1 2.3 2.4 2.5 2.9 3.0
Revenue 25,350 36,152 44,185 51,217 59,683 69,863 82,499
Change yoy, % 15.4 42.6 22.2 15.9 16.5 17.1 18.1
EBIDTA 4,181 5,847 7,103 8,219 9,253 10,723 12,180
EBITDA Margin % 16.5 16.2 16.1 16.0 15.5 15.3 14.8
Interest Cost 596 528 633 810 990 1,309 1,344
PAT 2,110 3,388 4,214 4,701 5,091 5,866 6,907
Change yoy, % 27.3 60.6 24.4 11.6 8.3 15.2 17.7
PAT Margin % 8.3 9.4 9.5 9.2 8.5 8.4 8.4
WC as a % of sales 2.0 14.8 10.3 20.7 24.7 22.6 20.3
Net debt (INR bn) 317 1,574 3,278 3,526 8,365 8,767 6,422
Net debt/ equity (x) 0.03 0.12 0.18 0.15 0.30 0.26 0.16
Capex (INR bn) 587 568 3,418 1,810 750 750 750
CFO (INR bn) 5,273 1,140 5,871 2,711 4,153 6,528 7,384
CFO/ EBITDA 1.3 0.2 0.8 0.3 0.4 0.6 0.6
Source: Company, Antique
May/24
Sep/19
Apr/20
Nov/20
Jun/21
Jan/22
Aug/22
Oct/23
Mar/23
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 44,185 51,217 59,683 69,863 82,499 PBT 5,687 6,124 6,870 7,917 9,321
Op. Expenses 37,082 42,998 50,430 59,140 70,320 Depreciation & amortization 963 1,412 1,518 1,601 1,683
EBITDA 7,103 8,219 9,253 10,723 12,180 Interest expense 633 810 990 1,309 1,344
Depreciation 963 1,412 1,518 1,601 1,683 (Inc)/Dec in working capital 65 (3,937) (3,300) (2,125) (2,361)
EBIT 6,140 6,808 7,734 9,122 10,496 Tax paid (1,571) (1,931) (1,779) (2,050) (2,414)
Other income 181 126 126 103 168 Other operating Cash Flow 94 233 (146) (123) (188)
Interest Exp. 633 810 990 1,309 1,344 CF from operating activities 5,871 2,711 4,153 6,528 7,384
Extra Ordinary Items -gain/(loss) - 1,067 - - - Capital expenditure (3,177) (2,051) (750) (750) (750)
Reported PBT 5,687 7,191 6,870 7,917 9,321 Inc/(Dec) in investments (2,628) 908 (7,280) (5,680) (2,980)
Tax 1,474 1,737 1,779 2,050 2,414 Add: Interest/Div. Income Recd. 81 88 126 103 168
Reported PAT 4,214 5,454 5,091 5,866 6,907 CF from investing activities (5,725) (1,055) (7,904) (6,327) (3,562)
Net Profit 4,214 5,454 5,091 5,866 6,907 Inc/(Dec) in share capital - 1 - - -
Adjusted PAT 4,214 4,387 5,091 5,866 6,907 Inc/(Dec) in debt 1,888 (525) 4,000 1,500 (1,000)
Adjusted EPS (INR) 64.7 67.3 78.1 90.0 106.0 Dividend Paid (65) (81) (98) (113) (134)
Others (648) (851) (990) (1,309) (1,344)
Balance sheet (INR mn) CF from financing activities 1,174 (1,456) 2,912 78 (2,477)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Net cash flow 1,321 200 (839) 279 1,345
Share capital 652 652 652 652 652 Opening balance 473 1,794 1,993 1,154 1,433
Reserves & Surplus 17,133 22,533 27,526 33,278 40,052 Closing balance 1,794 1,993 1,154 1,433 2,778
Networth 17,784 23,185 28,177 33,930 40,703
Debt 5,071 4,599 8,599 10,099 9,099 Growth indicators (%)
Other Non Current Liabilities 339 897 1,031 1,188 1,390 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net deferred Tax liabilities 141 121 121 121 121 Revenue 22.2 15.9 16.5 17.1 18.1
Capital Employed 23,336 28,803 37,929 45,339 51,314 EBITDA 21.5 15.7 12.6 15.9 13.6
Gross Fixed Assets 10,942 13,429 14,179 14,929 15,679 Adj PAT 24.4 4.1 16.0 15.2 17.7
Accumulated Depreciation 4,595 6,007 7,525 9,126 10,810 Adj EPS 24.4 4.1 16.0 15.2 17.7
Capital work in progress 719 42 42 42 42
Net Fixed Assets 7,066 7,464 6,696 5,845 4,911 Valuation (x)
Investments 7,447 6,276 13,576 19,276 22,276 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Other Non Current Assets 709 1,496 1,769 2,000 2,286 P/E (x) 18.7 17.9 15.5 13.4 11.4
Current Investments 15,222 15,236 22,041 27,120 29,473 P/BV (x) 4.4 3.4 2.8 2.3 1.9
Current Assets, Loans & Adv. 19,870 25,777 30,149 34,916 41,663 EV/EBITDA (x) 11.5 9.9 9.3 8.1 7.0
Inventory 2,353 2,967 5,043 5,323 5,063 EV/Sales (x) 1.9 1.6 1.4 1.3 1.0
Debtors 8,712 9,138 10,648 12,575 15,097 Dividend Yield (%) 0.1 0.1 0.1 0.1 0.2
Cash & Bank balance 1,794 1,993 1,154 1,433 2,778
Loans & advances and others 7,011 11,680 13,304 15,586 18,724
Financial ratios
Current Liabilities & Provisions 11,756 12,210 14,260 16,698 19,822
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 26.8 21.4 19.8 18.9 18.5
Liabilities 11,756 12,210 14,260 16,698 19,822
RoCE (%) 31.9 27.4 24.3 22.8 22.7
Net Current Assets 8,114 13,567 15,888 18,219 21,841
Asset/T.O (x) 3.1 2.8 2.7 3.0 3.2
Application of Funds 23,336 28,803 37,929 45,339 51,314
Net Debt/Equity (x) 0.29 0.20 0.31 0.30 0.22
Per share data EBIT/Interest (x) 10.0 8.6 7.9 7.0 7.9
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
No. of shares (mn) 65.2 65.2 65.2 65.2 65.2
Margins (%)
Diluted no. of shares (mn) 65.2 65.2 65.2 65.2 65.2
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
EBITDA Margin (%) 16.1 16.0 15.5 15.3 14.8
BVPS (INR) 272.9 355.8 432.4 520.6 624.6
EBIT Margin 13.9 13.3 13.0 13.1 12.7
CEPS (INR) 79.4 105.4 101.4 114.6 131.8
PAT Margin 9.5 8.6 8.5 8.4 8.4
DPS (INR) 1.3 1.5 1.5 1.7 2.0
Source: Company Antique
Source: Company, Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 52
Story in charts
Exhibit 1: Steady growth in sales and collections Exhibit 2: Robust cash flow generation
8,000 6.0 45%
39%
7,000 36% 40%
5.0 34%
4,376
6,000 31% 35%
4,040
3,420
3,308
3,310
5,000
3,210
4.0 30%
3,040
2,960
2,880
2,850
2,700
2,670
2,525
4,000 23%
2,130
2,070
25%
1,722
3.0
1,410
3,000
20%
2,000
651
1,012
2,003
3,492
3,710
1,760
2,716
3,520
5,030
3,330
3,370
3,960
5,370
3,869
3,950
4,546
6,780
5,020
5,240
2.0 15%
1,000
10%
- 1.0
2.8
2.4
4.3
4.8
1QFY21
2QFY21
3QFY21
4QFY21
1QFY22
2QFY22
3QFY22
4QFY22
1QFY23
2QFY23
3QFY23
4QFY23
1QFY24
2QFY24
3QFY24
4QFY24
1QFY25
2QFY25
5%
1.9
- 0%
FY21 FY22 FY23 FY24 1HFY25
Pre-sales value (INRm) Collection (INR mn) LHS: Cashflow (INR bn) RHS: Collection/Cashflow
7.6
5.6
6.3
3.7
0.7
FY 17
FY 18
FY 19
FY20
FY21
FY22
FY23
FY24
1HFY25
-0.3
-1.0 -0.05
FY19 FY20 FY21 FY22 FY23 FY24 1HFY25
Net adj debt (INR bn) net D/E (x) Luxury High mid-income Low mid-income Others
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 3,624 5,648 14,157 10,928 8,139 PBT 45 950 3,474 3,082 2,541
Op. Expenses 2,983 4,476 10,079 7,335 5,178 Depreciation & amortisation 92 95 295 298 301
EBITDA 642 1,173 4,078 3,594 2,961 Interest expense 859 684 309 214 119
Depreciation 92 95 295 298 301 (Inc)/Dec in working capital 2,022 (502) 26,462 7,022 6,173
EBIT 549 1,078 3,783 3,295 2,660 Tax paid (68) (121) (893) (792) (653)
Other income 284 555 555 555 555 Less: Interest/Dividend Income Received (267) (84) (555) (555) (555)
Interest Exp. 859 684 309 214 119 Other operating Cash Flow (63) 69 (97) (97) (97)
Reported PBT (25) 949 4,029 3,636 3,096 CF from operating activities 2,620 1,090 28,995 9,171 7,829
Tax 31 240 893 792 653 Capital expenditure (183) 2,188 118 (50) (50)
Reported PAT (56) 708 3,136 2,844 2,443 Inc/(Dec) in investments 247 274 - - -
Minority Int./Profit (loss) From Asso. (70) (1) Others (227) 48 (1,252) 1,205 1,117
Net Profit 14 709 3,136 2,844 2,443 CF from investing activities (162) 2,511 (1,134) 1,155 1,067
Adjusted PAT 14 709 3,136 2,844 2,443 Inc/(Dec) in share capital 7 2 - - -
Adjusted EPS (INR) 0.1 4.8 21.4 19.4 16.7 Inc/(Dec) in debt (1,647) (2,784) (1,000) (1,000) (1,000)
Dividend Paid (211) (211) (264) (264) (264)
Balance sheet (INR mn) Others (762) (534) (309) (214) (119)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e CF from financing activities (2,614) (3,527) (1,572) (1,477) (1,382)
Share Capital 140 146 146 146 146 Net cash flow (156) 74 26,288 8,849 7,514
Reserves & Surplus 27,738 31,095 33,413 35,439 37,064 Opening balance 438 283 356 26,645 35,493
Networth 27,879 31,242 33,560 35,586 37,210 Closing balance 283 356 26,645 35,493 43,007
Debt 6,885 3,791 2,791 1,791 791
Net deferred Tax liabilities 9 59 59 59 59 Growth indicators (%)
Others 90 173 173 173 173 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Capital Employed 34,862 35,266 36,583 37,609 38,234 Revenue(%) -29.4 55.8 150.6 -22.8 -25.5
Goodwill 1 23 23 23 23 EBITDA(%) -32.7 82.8 247.7 -11.9 -17.6
Property, Plant and Equipment 1,490 4,881 4,764 4,814 4,864 Adj PAT(%) -94.1 4934.3 342.1 -9.3 -14.1
Capital work in progress 1,025 185 185 185 185 Adj EPS(%) -94.1 4727.9 342.1 -9.3 -14.1
Other Non-Current Assets 1,734 2,900 2,900 2,900 2,900
Net Fixed Assets 4,248 7,966 7,849 7,899 7,949 Valuation (x)
Investments 2,407 2,295 2,295 2,295 2,295 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Non Current Investments 2,407 2,295 2,295 2,295 2,295 P/E (x) 4895.7 101.4 22.9 25.3 29.4
Current Assets, Loans & Adv. 65,930 68,951 72,510 72,114 71,610 P/BV (x) 2.5 2.3 2.1 2.0 1.9
Inventory 57,251 59,663 33,101 25,837 19,562 EV/EBITDA (x) 9.5 2.8 -5.8 -9.4 -14.2
Debtors 1,496 2,925 5,149 4,019 3,043 EV/Sales (x) 1.7 0.6 -1.7 -3.1 -5.2
Cash & cash equivalents 888 597 26,645 35,493 43,007
Bank balance 694 461 461 461 461
Financial ratios
Loans & advances and others 5,601 5,305 7,155 6,304 5,537
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 0.1 2.4 9.7 8.2 6.7
Current Liabilities & Provisions 37,725 43,971 46,094 44,722 43,644
RoCE (%) 2.4 4.7 12.1 10.4 8.5
Liabilities 37,672 43,906 46,029 44,657 43,579
Asset/T.O (x) 0.1 0.2 0.4 0.3 0.2
Provisions 52 65 65 65 65
Net Debt/Equity (x) 0.2 0.1 -0.7 -0.9 -1.1
Net Current Assets 28,206 24,980 26,416 27,392 27,966
EBIT/Interest (x) 0.6 1.6 12.3 15.4 22.4
Application of Funds 34,862 35,266 36,583 37,609 38,233
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
28% 1QFY20 82
1QFY20 35% 2QFY20 75
2QFY20 8%
19% 3QFY20 81
3QFY20 -8%
-16% 4QFY20 84
-4%
-22%
56 4QFY24 22%
2 24% 2QFY25 111
2QFY21 1QFY25 23%
56 73%
2QFY25 -17%-9%
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3
3QFY21
60
0%
20%
40%
60%
80%
Standalone
62 2QFY20 15%
5 3QFY20
1QFY22 13% 1QFY20
62
4 4QFY20 18% 2QFY20
Railway
2QFY22
65 1QFY21 14% 3QFY20
Road HAM
68
5 3QFY21 11% 1QFY21
4QFY22
67 4QFY21 15% 2QFY21
9
-
1QFY23 3QFY21
71 1QFY22 12%
4QFY21
Exhibit 2: Order book trend
9 2QFY22 12%
2QFY23 1QFY22
71 3QFY22
8 11%
3QFY23 2QFY22
70 4QFY22 10% 3QFY22
Road EPC
9 1QFY23 10%
4QFY23 4QFY22
69
EPC Buildings
10 2QFY23 9% 1QFY23
Consolidated
1QFY24
70 3QFY23 8% 2QFY23
11 4QFY23 3QFY23
2QFY24 7%
72
11 1QFY24 5% 4QFY23
3QFY24
69 2QFY24 9% 1QFY24
11 2QFY24
Others
4QFY24 3QFY24 8%
71
14 4QFY24 7% 3QFY24
Power T&D
1QFY25 4QFY24
72 1QFY25 6%
13 1QFY25
2QFY25 2QFY25 8%
69 2QFY25
14 November 2024 | 61
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 62
Table 4: Snapshot
INR mn FY19 FY20 FY21 FY22 FY23 FY24 FY25E FY26E FY27E
Order Book 83,943 83,719 81,669 1,37,309 1,58,050 1,16,970 1,43,279 1,82,326 2,31,710
Order Inflow 66,204 39,226 36,052 1,01,555 1,00,000 36,187 1,00,000 1,20,000 1,40,000
Book to bill x 2.2 2.4 2.3 1.8 1.8 2.0 2.3
Revenue 38,206 39,374 38,175 45,915 63,723 77,267 73,691 80,953 90,616
Change yoy, % 56% 3% -3% 20% 39% 21% -5% 10% 12%
EBITDA 5,152 5,856 5,195 5,025 5,337 5,765 5,895 7,488 8,609
EBITDA Margin % 13% 15% 14% 11% 8% 7% 8% 9% 10%
Interest Cost 907 855 772 697 1,410 2,281 2,703 2,544 2,316
PAT 3,332 3,871 4,081 4,610 3,221 2,761 2,469 3,730 4,689
Change yoy, % 41% 16% 5% 13% -30% -14% -11% 51% 26%
PAT Margin % 7% 10% 11% -7% 11% 6% 3% 5% 5%
Table 6: SoTP-based TP
FY27E Base
Core EPC PAT (INR mn) 3,940
Multiple (x) 14.0
Equity value (INR mn) 55,155
No. of shares (mn) 281
Equity value (INR/sh) 196
BV Investments in Subs FY24 (INR/sh) 56
Target price (INR) 253
Source: Company, Antique
Exhibit 7: PE band
35
30
25
20
15
10
0 May/18
Feb/20
Nov/14
Jun/15
Jan/16
Aug/16
Dec/18
Jul/19
Sep/20
Nov/21
Jun/22
Jan/23
Aug/23
Mar/17
Oct/17
Apr/21
Mar/24
Oct/24
PER +1 Stdev -1 Stdev Avg PER
Source: Company, Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 64
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 March FY23 FY24 FY25e FY26e FY27e Year ended 31 March FY23 FY24 FY25e FY26e FY27e
Net Revenue 63,723 77,267 73,691 80,953 92,986 PBT 7,733 5,755 3,299 4,782 6,480
Op. Expenses 58,387 71,502 67,796 73,667 84,153 Depreciation & amortization 742 1,046 1,063 1,153 1,243
EBITDA 5,337 5,765 5,895 7,286 8,834 Interest expense 1,410 2,281 2,703 2,544 2,327
Depreciation 742 1,046 1,063 1,153 1,243 (Inc)/Dec in working capital (3,136) (342) (3,232) (1,277) (1,787)
EBIT 4,594 4,719 4,833 6,133 7,591 Tax paid (1,390) (1,526) (830) (1,203) (1,630)
Other income 1,057 1,146 1,169 1,192 1,216 Less: Interest/Div. Income Recd. (729) (764) - - -
Interest Exp. 1,410 2,281 2,703 2,544 2,327 Other operating Cash Flow (2,493) (67) 2,703 2,544 2,327
Extra Ordinary Items -gain/(loss) 3,492 2,171 - - - CF from operating activities 2,137 6,382 5,705 8,542 8,959
Reported PBT 7,733 5,755 3,299 4,782 6,480 Capital expenditure (1,096) (1,159) (1,000) (1,000) (1,000)
Tax 1,020 1,327 830 1,203 1,630 Inc/(Dec) in investments (3,034) (1,907) (1,000) (2,000) (2,000)
Reported PAT 6,713 4,428 2,469 3,579 4,850 Add: Interest/Div. Income Recd. 221 251 - - -
Net Profit 6,713 4,428 2,469 3,579 4,850 CF from investing activities (3,909) (2,815) (2,000) (3,000) (3,000)
Adjusted PAT 3,221 2,761 2,469 3,579 4,850 Inc/(Dec) in debt 4,723 3,994 (623) (1,184) (1,065)
Adjusted EPS (INR) 11.5 9.8 8.8 12.7 17.3 Others (1,474.42) (4,319.50) (5,405.22) (5,087.76) (4,653.90)
CF from financing activities 3,248 (326) (6,028) (6,271) (5,719)
Balance sheet (INR mn) Net cash flow 1,477 3,241 (2,323) (730) 240
Year ended 31 March FY23 FY24 FY25e FY26e FY27e Opening balance 388 1,865 5,106 2,783 2,053
Share capital 1,404 1,404 1,404 1,404 1,404 Closing balance 1,865 5,106 2,783 2,053 2,293
Reserves & Surplus 32,294 36,721 39,190 42,769 47,619
Networth 33,697 38,125 40,594 44,172 49,022 Growth indicators (%)
Debt 9,973 14,427 13,804 12,620 11,554 Year ended 31 March FY23 FY24 FY25e FY26e FY27e
Other Non Current Liabilities 5,510 5,488 5,537 5,590 5,648 Revenue 38.8 21.3 -4.6 9.9 14.9
Capital Employed 49,180 58,040 59,934 62,382 66,225 EBITDA 6.2 8.0 2.3 23.6 21.2
Gross Fixed Assets 9,760 11,308 12,308 13,308 14,308 Adj PAT -30.1 -14.3 -10.6 44.9 35.5
Accumulated Depreciation 6,989 8,035 9,098 10,251 11,493 Adj EPS -30.1 -14.3 -10.6 44.9 35.5
Capital work in progress 335 22 22 22 22
Net Fixed Assets 3,107 3,295 3,232 3,079 2,837 Valuation (x)
Investments 13,537 14,799 15,799 17,799 19,799 Year ended 31 March FY23 FY24 FY25e FY26e FY27e
Other Non Current Assets 2,264 5,950 5,950 5,950 5,950 P/E (x) 20.3 23.7 26.5 18.3 13.5
Current Assets, Loans & Adv. 53,093 63,295 61,532 62,489 67,312 P/BV (x) 1.9 1.7 1.6 1.5 1.3
Inventory 2,984 4,327 4,102 4,458 5,092 EV/EBITDA (x) 13.8 13.0 13.0 10.4 8.5
Debtors 11,490 10,985 10,731 10,993 13,105 EV/Sales (x) 1.2 1.0 1.0 0.9 0.8
Cash & Bank balance 1,865 5,106 2,783 2,053 2,293
Loans & advances and others 36,754 42,877 43,916 44,985 46,821
Financial ratios
Current Liabilities & Provisions 22,820 29,299 26,579 26,935 29,672
Year ended 31 March FY23 FY24 FY25e FY26e FY27e
RoE (%) 10.6 7.7 6.3 8.4 10.4
Liabilities 22,605 29,164 26,173 26,434 29,054
RoCE (%) 14.8 12.2 11.2 13.2 15.0
Provisions 215 135 407 501 618
Asset/T.O (x) 2.2 2.2 2.0 2.1 2.4
Net Current Assets 30,273 33,996 34,953 35,554 37,640
Net Debt/Equity (x) 0.2 0.2 0.3 0.2 0.2
Application of Funds 49,180 58,040 59,934 62,382 66,225
EBIT/Interest (x) 4.0 2.6 2.2 2.9 3.8
Per share data
Year ended 31 March FY23 FY24 FY25e FY26e FY27e
Margins (%)
No. of shares (mn) 280.7 280.7 280.7 280.7 280.7
Year ended 31 March FY23 FY24 FY25e FY26e FY27e
EBITDA Margin (%) 8.4 7.5 8.0 9.0 9.5
Diluted no. of shares (mn) 280.7 280.7 280.7 280.7 280.7
EBIT Margin 7.2 6.1 6.6 7.6 8.2
BVPS (INR) 120.0 135.8 144.6 157.4 174.6
PAT Margin 5.1 3.6 3.4 4.4 5.2
CEPS (INR) 26.6 19.5 12.6 16.9 21.7
Source: Company Antique
Source: Company, Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 65
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Revenues 5,524 8,022 10,680 14,666 15,988 PBT 597 1,156 1,495 2,238 2,571
Expenses 4,833 6,559 8,745 11,971 13,006 Depreciation 20 118 171 209 243
EBITDA 691 1,463 1,935 2,695 2,982 Interest 98 221 310 305 232
Depreciation & amortization 20 118 171 209 243 (Inc)/ Dec in working capital (430) (544) (866) (1,112) (630)
EBIT 671 1,345 1,764 2,486 2,740 Tax paid (155) (297) (389) (582) (668)
Other income 24 32 41 57 64 CF from operating activities 130 655 721 1,058 1,747
Interest expense 98 221 310 305 232 Capex (1,612) (1,239) (1,350) (800) (850)
Profit before tax 597 1,156 1,495 2,238 2,571 (Inc)/ Dec in Investments (15) (2) - - -
Tax 155 297 389 582 668 CF from investing activities (1,627) (1,242) (1,350) (800) (850)
Profit after tax 442 860 1,106 1,656 1,903 Inc/ (Dec) in share capital and premium 1,505 - 179 - -
Adj. PAT after minority int. 442 860 1,106 1,656 1,903 Inc/ (Dec) in debt 215 589 800 145 (580)
EPS (INR) 21.8 42.4 54.5 81.6 93.7 Dividends & Interest paid (109) (241) (344) (345) (277)
Others 72 56 -
Balance sheet (INR mn) CF from financing activities 1,683 404 634 (201) (857)
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e Net cash flow 186 (183) 5 57 40
Share Capital 203 203 203 203 203 Add: Opening balance 73 260 76 82 139
Reserves & Surplus 1,017 1,856 2,928 4,544 6,401 Closing balance 260 76 82 139 179
Premium A/c 2,002 2,002 2,181 2,181 2,181
Networth 3,222 4,061 5,311 6,927 8,785 Growth indicators (%)
Debt 905 1,493 2,293 2,438 1,857 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Deferred tax/ other liabilities 15 75 75 75 75 Revenue 42.8 45.2 33.1 37.3 9.0
Capital Employed 4,141 5,629 7,679 9,440 10,717 EBITDA 40.4 111.7 32.2 39.3 10.7
Gross Fixed Assets 683 3,017 4,379 5,214 6,064 PAT 39.6 94.5 28.7 49.7 14.9
Accumulated Depreciation 85 199 370 578 821 EPS 4.7 94.5 28.7 49.7 14.9
Net Assets 599 2,818 4,009 4,635 5,243
Capital work in progress 1,216 121 110 75 75 Valuation (x)
Investments 29 31 31 31 31 Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Liquid Investments 29 31 31 31 31 P/E (x) 85.1 43.8 34.0 22.7 19.8
Current Assets Loans & Advances P/BV (x) 11.7 9.3 7.1 5.4 4.3
Inventory 1,669 2,259 3,037 4,022 4,548 EV/EBITDA (x) 55.4 26.7 20.6 14.8 13.2
Debtors 705 1,771 2,195 2,813 3,110 EV/Sales (x) 6.9 4.9 3.7 2.7 2.5
Cash & Bank 260 76 82 139 179 Dividend Yield (%) 0.0 0.1 0.1 0.1 0.1
Loans & advances and others 597 498 732 1,005 1,095
Current Liabilities & Provisions
Financial ratios
Creditors 927 1,936 2,501 3,261 3,543
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE 19.6 23.6 23.6 27.1 24.2
Provisions 6 11 15 19 21
RoCE 17.4 21.5 20.2 22.0 20.7
Net Current Assets 2,298 2,658 3,529 4,698 5,368
Debt/Equity (x) 0.2 0.3 0.4 0.3 0.2
Application of Funds 4,141 5,629 7,679 9,440 10,717
EBIT/Interest (x) 6.8 6.1 5.7 8.2 11.8
Per share data
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Margins (%)
No. of shares (mn) 20 20 20 20 20
Year ended 31 Mar FY23 FY24 FY25e FY26e FY27e
EBITDA 12.5 18.2 18.1 18.4 18.7
BVPS (INR) 158.8 200.1 261.7 341.3 432.8
EBIT 12.2 16.8 16.5 17.0 17.1
CEPS (INR) 22.8 48.2 62.9 91.9 105.7
PAT 8.0 10.7 10.4 11.3 11.9
DPS (INR) 0.5 1.0 1.7 2.0 2.2
Source: Company Antique
Source: Company, Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 69
(1)
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
0
500
1000
1500
2000
2500
3000
2QFY20 4.78 0.51 1.64
1QFY20 1080 1QFY21 1.05
3QFY20 5.20 0.56
2QFY20 810 1.94
INR bn
4QFY20 4.34 0.48 2QFY21 2.01
3QFY20 740 1QFY21 4.38 0.50 3QFY21 3.17
3.82
(INR mn)
Operating
4QFY20 1580
cash flows
INR/sqft
4QFY24 1670 2QFY25-0.58 -0.08 5.92
1QFY25 1QFY25 7.11
2470
-
6.12
Exhibit 1: 2QFY25: Steady pre-sales and uptick in collection
7.70
0.1
0.2
0.3
0.4
0.5
0.6
2QFY25 1950 2QFY25
-0.2
-0.1
5.50
-
0.2
0.4
0.6
0.8
1.0
1.2
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
-
1QFY21 0.31
1QFY21
2QFY21 0.35
2QFY21
3QFY21 0.55
3QFY21
Pune
FROM THE RESEARCH DESK
4QFY21 0.85
4QFY21
1QFY22 0.40
1QFY22
Exhibit 2: Steady volume
2QFY22 0.67
2QFY22
3QFY22
Exhibit 4: Realization steady
0.86
3QFY22
4QFY22 0.78
4QFY22
2% 3%
MMR
1QFY23 1QFY23 0.61
95%
2QFY24 2QFY24 0.98
3QFY24 3QFY24 0.98
Bengaluru
4QFY24 4QFY24 1.03
1QFY25 1QFY25 0.96
2QFY25 2QFY25 1.03
14 November 2024 | 73
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 74
Financials
Profit and loss account (INR mn) Cash flow statement (INR mn)
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Net Revenue 14,884 13,715 18,372 20,190 24,267 PBT 1,696 (611) 2,542 2,811 3,529
Op. Expenses 12,992 13,204 14,698 16,152 19,414 Depreciation & amortization 116 142 163 188 216
EBITDA 1,893 511 3,674 4,038 4,853 Interest expense 407 979 1,203 1,272 1,341
Depreciation 116 142 163 188 216 (Inc)/Dec in working capital 324 (1,192) 8,051 (2,123) (4,761)
EBIT 1,777 369 3,511 3,850 4,638 Tax paid (563) (354) (653) (723) (907)
Other income 326 233 233 233 233 Other operating Cash Flow (55) (74) (153) (153) (153)
Interest Exp. 407 979 1,203 1,272 1,341 CF from operating activities 1,925 (1,110) 11,152 1,273 (735)
Extra Ordinary Items -gain/(loss) - (235) - - - Capital expenditure (183) (419) (163) (188) (216)
Reported PBT 1,696 (611) 2,542 2,811 3,529 (Inc)/Dec in investments (429) (1,399) (275) (300) (300)
Tax 546 (34) 653 723 907 Interest Received 54 81 50 50 50
Reported PAT 1,150 (577) 1,888 2,089 2,622 Others 106 400 100 100 100
Minority Int./Profit (loss) From Associates (109) (116) CF from investing activities (453) (1,338) (288) (338) (366)
Net Profit 1,041 (694) 1,888 2,089 2,622 Inc/(Dec) in long-term debt 118 4,676 750 750 750
Adjusted PAT 1,041 (694) 1,371 1,517 1,904 Inc/(Dec) in short-term debt 1 - - - -
Adjusted EPS (INR) 13.7 (9.1) 18.0 20.0 25.1 Interest paid (529) (1,074) (1,203) (1,272) (1,341)
Dividend Paid (152) (304) (304) (304) (304)
Balance sheet (INR mn) Others (120) (110) - - -
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e CF from financing activities (682) 3,188 (757) (826) (895)
Share Capital 760 760 760 760 760 Net cash flow 790 740 10,107 109 (1,996)
Reserves & Surplus 9,704 6,579 7,646 8,859 10,459 Opening balance 1,464 2,258 2,995 13,102 13,211
Networth 10,464 7,339 8,406 9,619 11,219 Closing balance 2,255 2,998 13,102 13,211 11,215
Debt 5,415 10,786 11,536 12,286 13,036 Bank Balance 1,278 1,103 1,103 1,103 1,103
Minority Interest 86 16 534 1,129 1,870 On account of acquisition of subsidiary 3
Others 1,177 1,338 1,338 1,338 1,338 Cash and bank balance 3,533 4,100 14,205 14,314 12,318
Capital Employed 17,142 19,479 21,814 24,371 27,463
Property, Plant and Equipment 677 1,048 1,211 1,399 1,615 Growth indicators (%)
Capital work in progress 100 - - - - Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Other Non-Current Assets 4,489 5,415 5,415 5,415 5,415 Revenue 33.2 -7.9 34.0 9.9 20.2
Net Fixed Assets 5,266 6,463 6,626 6,814 7,030 EBITDA 1.6 -73.0 619.1 9.9 20.2
Goodwill 2,040 - - - - Adj PAT 31.1 -166.6 -297.7 10.6 25.5
Investments 197 1,238 1,513 1,813 2,113 Adj EPS 31.1 -166.6 -297.7 10.6 25.5
Non Current Investments 173 307 307 307 307
Current Investments 25 931 1,206 1,506 1,806 Valuation (x)
Current Assets, Loans & Adv. 34,698 41,773 42,693 45,381 49,168 Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
Inventory 28,938 34,685 25,721 28,266 33,974 P/E (x) 45.1 -67.7 34.2 31.0 24.7
Debtors 273 557 337 371 446 P/BV (x) 4.5 6.4 5.6 4.9 4.2
Cash & Bank balance 3,533 4,100 14,205 14,314 12,318 EV/EBITDA (x) 15.5 65.0 6.4 5.9 5.4
Loans & advances and others 1,954 2,430 2,430 2,430 2,430 EV/Sales (x) 2.0 2.4 1.3 1.2 1.1
Current Liabilities & Provisions 25,060 29,994 29,019 29,636 30,848
Liabilities 24,938 29,843 28,868 29,484 30,696
Financial ratios
Provisions 122 152 152 152 152
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
RoE (%) 10.4 -7.8 17.4 16.8 18.3
Net Current Assets 9,638 11,778 13,674 15,745 18,320
RoCE (%) 12.8 3.3 18.1 17.7 18.8
Application of Funds 17,142 19,479 21,813 24,372 27,463
Asset/T.O (x) 1.0 0.8 1.0 0.9 1.0
Per share data Net Debt/Equity (x) 0.2 0.8 -0.5 -0.4 -0.1
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e EBIT/Interest (x) 4.4 0.4 2.9 3.0 3.5
No. of shares (mn) 76 76 76 76 76
Diluted no. of shares (mn) 76 76 76 76 76
Margins (%)
BVPS (INR) 138 97 111 127 148
Year-ended 31 Mar FY23 FY24 FY25e FY26e FY27e
EBITDA Margin (%) 12.7 3.7 20.0 20.0 20.0
CEPS (INR) 16.7 -5.7 27.0 30.0 37.3
EBIT Margin (%) 11.9 2.7 19.1 19.1 19.1
DPS (INR) 4.0 4.0 4.0 4.0 0.0
PAT Margin (%) 6.8 -5.0 7.4 7.4 7.8
Source: Company, Antique
Source: Company Antique
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 75
Valuation Guide
Company Reco CMP TP Return M. Cap M. Cap Net profit (INR bn) EPS (INR) P/E (x) EV/EBITDA (x) P/BV (x) RoE (%) RoCE (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 FY26 FY26 1m 12m
AGROCHEM & FERTILIZERS
Bayer Cropscience Hold 6,079 5,540 (9) 273.2 3.2 7.8 9.4 10.5 173.2 208.4 234.2 35.1 29.2 26.0 26.5 22.1 19.6 8.8 30.9 39.8 -8 11
Coromandel Intl. Buy 1,685 2,170 29 496.3 5.9 17.4 19.9 25.8 57.1 66.3 86.7 29.5 25.4 19.4 18.1 15.9 12.2 4.0 17.4 24.7 4 52
Dhanuka Agritech Buy 1,525 2,090 37 68.7 0.8 2.8 3.1 3.8 62.4 69.8 83.3 24.4 21.9 18.3 16.9 14.9 12.3 4.1 19.9 26.8 3 78
Paradeep Phosphates Buy 107 140 31 87.0 1.0 4.5 6.0 7.3 5.5 7.3 9.0 19.5 14.6 11.9 10.6 8.7 7.7 2.0 14.3 14.4 17 69
PI Industries Buy 4,446 4,770 7 674.6 8.0 16.7 19.2 22.2 109.6 126.5 145.8 40.6 35.1 30.5 27.2 23.3 19.9 5.7 17.5 23.2 -3 21
Rallis India Sell 307 310 1 59.7 0.7 1.8 2.4 3.0 9.1 12.4 15.7 33.8 24.8 19.6 15.3 12.4 9.9 2.8 11.7 16.3 -5 44
Sharda Cropchem Buy 747 830 11 67.4 0.8 2.6 3.3 4.2 28.5 37.0 46.3 26.2 20.2 16.1 10.8 8.5 6.7 2.4 12.7 16.3 31 78
Sumitomo Chemical India Buy 511 630 23 254.9 3.0 5.4 6.5 7.8 10.8 13.1 15.7 47.3 39.0 32.5 36.7 30.2 25.2 7.3 20.4 27.2 -5 35
UPL Buy 515 740 44 386.9 4.6 10.3 25.3 37.0 13.7 33.8 49.3 37.6 15.3 10.4 7.5 6.2 5.1 1.5 9.9 11.9 -11 -7
BUILDING MATERIALS
Apollo Pipes Buy 481 730 52 19.9 0.2 0.5 0.6 1.0 10.7 14.3 22.6 45.1 33.7 21.3 17.2 12.9 8.9 2.4 7.5 10.6 -13 -31
Astral Buy 1,730 2,450 42 464.8 5.5 6.7 8.4 10.1 24.8 31.2 37.7 69.8 55.4 45.9 40.9 33.0 27.6 10.2 20.2 26.3 -9 -8
Cera Sanitaryware Hold 6,765 8,820 30 87.3 1.0 2.5 2.8 3.2 191.9 217.8 251.9 35.3 31.1 26.9 27.0 22.7 18.9 5.7 19.6 25.4 -14 -24
Finolex Industries Hold 263 270 3 163.4 1.9 6.2 6.5 7.4 10.0 10.6 12.0 26.4 25.0 22.0 22.0 20.4 17.9 2.4 10.0 11.9 -17 37
Greenlam Industries Buy 519 800 54 66.3 0.8 1.3 2.1 3.2 10.3 16.6 24.8 50.5 31.2 21.0 22.4 15.1 12.0 4.9 16.7 16.1 2 -8
Greenpanel Industries Buy 342 550 61 41.9 0.5 0.9 1.5 2.7 7.0 12.5 21.9 48.6 27.3 15.6 24.3 13.4 8.8 2.7 9.9 8.1 -18 4
Kajaria Ceramics Buy 1,142 1,500 31 181.9 2.2 4.3 5.5 6.8 27.0 34.3 42.7 42.2 33.3 26.7 24.2 19.5 15.7 5.3 17.2 22.4 -19 -11
Prince Pipes and Fittings Buy 442 690 56 48.9 0.6 1.3 1.8 2.5 11.5 16.4 22.7 38.5 27.0 19.5 18.7 14.1 10.5 2.7 10.4 13.4 -19 -37
Somany Ceramics Buy 655 900 38 26.8 0.3 1.0 1.4 1.8 24.5 33.0 45.0 26.7 19.9 14.6 11.2 9.1 7.1 2.9 15.6 17.5 -8 -4
Supreme Industries Buy 4,516 6,380 41 573.7 6.8 12.1 14.2 16.2 95.1 112.0 127.6 47.5 40.3 35.4 32.1 27.5 24.2 8.4 22.4 26.6 -15 6
CEMENT
ACC Buy 2,198 2,600 18 412.7 4.9 16.0 21.2 25.8 85.1 112.7 137.2 25.8 19.5 16.0 12.7 10.0 8.3 2.1 11.3 15.6 -5 20
Ambuja Cement Buy 545 680 25 1,343.3 15.9 27.2 29.9 41.2 11.1 12.1 16.7 49.3 45.0 32.6 24.5 18.1 14.3 2.5 5.6 9.8 -7 30
Birla Corp Buy 1,085 1,500 38 83.5 1.0 2.0 4.0 4.9 26.3 52.0 64.2 41.2 20.9 16.9 9.9 8.0 7.1 1.1 5.5 7.2 -12 -15
Dalmia Bharat Hold 1,738 1,930 11 325.9 3.9 8.1 12.4 14.0 43.1 65.9 74.7 40.3 26.4 23.3 13.1 10.9 10.0 1.7 6.6 8.1 -8 -18
Grasim Industries Buy 2,503 3,000 20 1,683.2 19.9 8.6 14.8 19.5 13.0 22.2 29.4 192.1 112.6 85.1 101.8 69.4 54.6 3.0 2.7 3.6 -8 30
Heidelberg Hold 216 190 (12) 49.0 0.6 1.7 2.2 2.6 7.4 9.6 11.3 29.4 22.5 19.0 13.8 11.0 9.4 3.4 15.3 18.3 -3 15
JK Cement Buy 3,974 5,000 26 307.1 3.6 7.1 9.0 11.2 91.6 117.1 145.1 43.4 33.9 27.4 17.1 14.4 12.2 4.6 14.3 14.0 -7 16
JK Lakshmi Cement Hold 709 890 26 83.5 1.0 4.9 5.9 6.4 41.8 47.8 51.2 17.0 14.8 13.9 9.4 8.4 7.8 2.3 16.5 14.8 -13 -9
Nuvoco Vistas Hold 329 370 13 117.4 1.4 0.3 2.3 3.7 0.8 6.5 10.5 387.9 50.2 31.3 11.0 9.3 8.2 1.3 2.6 5.6 -7 -5
Orient Cement Hold 337 315 (6) 69.0 0.8 1.2 2.8 3.8 5.8 13.8 18.5 57.7 24.5 18.2 19.6 13.1 10.6 3.3 14.3 15.5 15 55
Shree Cements Buy 24,049 28,800 20 867.7 10.3 14.3 20.3 25.5 396.4 563.2 707.2 60.7 42.7 34.0 19.7 15.6 13.1 3.7 9.0 11.7 -2 -8
Ramco Cement Hold 884 920 4 208.9 2.5 2.1 5.2 7.2 8.9 22.0 30.4 99.6 40.2 29.1 17.6 13.7 11.6 2.7 6.8 8.8 2 -11
UltraTech Cement Buy 10,782 12,800 19 3,112.8 36.9 68.0 89.3 116.0 230.6 303.0 393.8 46.8 35.6 27.4 24.5 18.6 14.8 4.5 13.2 16.6 -5 24
FMCG
Asian Paints Hold 2,471 2,527 2 2,369.7 28.1 43.7 48.3 53.9 45.6 50.3 56.2 54.2 49.1 44.0 38.1 33.8 29.7 10.2 22.1 25.8 -19 -20
Bajaj Consumer Care Buy 204 284 39 28.1 0.3 1.6 1.8 2.0 11.1 12.6 14.2 18.3 16.2 14.4 11.6 9.5 7.7 2.1 13.3 16.2 -10 -9
Colgate Palmolive Hold 2,763 3,054 11 751.5 8.9 14.7 16.7 18.5 54.0 61.6 67.9 51.1 44.9 40.7 35.0 31.0 28.0 28.5 69.5 105.5 -22 30
Dabur India Buy 511 710 39 905.4 10.7 19.2 22.0 25.1 10.9 12.5 14.2 47.1 41.0 36.0 35.3 30.8 26.9 7.7 19.7 23.2 -10 -4
Emami Buy 650 884 36 285.3 3.4 8.8 9.8 11.0 20.2 22.4 25.3 32.2 28.9 25.7 26.1 23.2 20.3 8.9 32.9 39.7 -10 27
Godrej Consumer Buy 1,184 1,605 36 1,211.1 14.3 21.7 27.9 32.8 21.3 27.3 32.1 55.7 43.4 36.9 36.1 30.6 26.2 8.2 19.8 25.8 -10 21
Hindustan Unilever Hold 2,465 2,666 8 5,791.6 68.6 104.5 114.8 125.3 44.5 48.9 53.3 55.4 50.4 46.2 38.1 34.5 31.5 11.5 22.6 27.9 -11 0
Honasa Consumer Hold 364 450 24 118.3 1.4 1.5 2.1 2.8 4.7 6.3 8.7 78.2 57.4 42.1 38.9 27.4 19.2 8.1 15.2 29.5 -14 15
ITC Buy 472 557 18 5,907.1 70.0 209.2 238.9 270.2 16.8 19.1 21.6 28.2 24.7 21.8 22.1 19.0 16.3 5.8 26.0 33.5 -5 8
Jyothy Labs Buy 436 561 29 160.1 1.9 4.1 4.5 5.2 11.2 12.4 14.0 39.0 35.3 31.1 29.5 26.2 22.6 6.9 20.9 27.4 -16 0
Kansai Nerolac Buy 262 370 41 212.0 2.5 7.2 8.4 10.0 8.9 10.3 12.3 29.6 25.3 21.3 17.5 14.9 12.4 3.3 13.5 18.6 -9 -15
Marico Buy 597 823 38 773.2 9.2 15.8 18.2 21.2 12.2 14.1 16.5 48.8 42.3 36.3 34.6 29.5 25.3 15.4 39.3 45.2 -13 15
Nestle Hold 2,235 2,563 15 2,155.1 25.5 32.7 36.3 41.2 33.9 37.6 42.7 66.0 59.4 52.3 44.3 39.9 35.2 37.2 69.0 94.6 -11 -7
Patanjali Foods Buy 1,843 2,100 14 667.2 7.9 14.4 21.7 25.3 39.8 59.9 70.0 46.3 30.8 26.3 33.3 21.6 17.8 5.0 17.5 21.9 7 27
Radico Khaitan Buy 2,258 2,500 11 302.0 3.6 4.1 5.4 6.7 30.4 40.4 50.0 74.2 55.9 45.2 43.5 35.3 29.3 9.5 18.3 20.8 3 61
United Spirits Buy 1,428 1,703 19 1,038.4 12.3 15.1 17.9 20.6 20.8 24.6 28.4 68.8 58.0 50.3 49.2 41.8 35.8 11.4 21.0 34.7 -7 37
RETAIL
Aditya Birla Fashion & Retail Hold 290 325 12 310.7 3.7 -2.2 1.6 4.5 -2.2 1.6 4.4 -133.5 181.1 65.2 17.9 13.8 11.3 7.4 4.2 8.3 -16 35
Arvind Fashions Buy 549 700 27 73.3 0.9 1.1 1.8 2.6 7.9 13.4 19.6 69.2 40.9 28.0 12.5 9.7 7.6 5.1 12.4 19.8 -12 42
Avenue Supermarts Hold 3,760 5,026 34 2,446.5 29.0 32.2 38.7 47.0 49.5 59.5 72.3 76.0 63.2 52.0 49.6 41.1 33.7 9.3 14.7 19.8 -10 -1
Devyani International Buy 169 205 21 204.0 2.4 0.8 1.5 2.0 0.7 1.3 1.7 245.8 133.5 101.0 23.8 18.6 15.8 15.8 12.6 22.0 -6 -7
Jubilant Foodworks Hold 625 584 (7) 412.5 4.9 3.2 4.9 6.4 4.9 7.5 9.7 128.8 83.9 64.3 26.7 22.2 19.2 15.9 20.0 29.0 1 24
Kewal Kiran Buy 602 1,040 73 37.1 0.4 1.6 1.9 2.1 26.6 31.3 34.7 22.6 19.3 17.4 16.6 14.5 12.7 4.0 20.7 23.6 -10 -23
Restaurant Brands Asia Buy 85 133 57 42.2 0.5 -0.8 -0.8 -0.4 -1.6 -1.6 -0.7 -53.4 -53.2 -118.6 12.1 9.5 7.5 2.5 -4.6 9.3 -20 -27
Sapphire Foods India Buy 309 416 35 99.2 1.2 0.4 0.9 1.9 1.4 3.0 5.9 222.8 104.4 52.0 18.8 13.7 10.1 6.7 6.6 18.8 -13 17
Senco Gold Buy 1,059 1,709 61 82.3 1.0 2.3 2.6 3.3 29.4 34.0 42.7 36.1 31.1 24.8 21.0 18.1 15.3 4.7 15.0 13.6 -24 52
Shoppers Stop Buy 626 1,016 62 68.8 0.8 0.2 1.4 2.8 1.5 12.6 25.8 422.0 49.8 24.2 10.0 7.9 6.1 14.4 28.9 14.5 -18 -6
Titan Co Ltd Buy 3,188 4,598 44 2,830.1 33.5 37.9 55.2 68.0 42.7 62.2 76.6 74.7 51.3 41.6 49.2 36.0 29.8 17.2 38.6 24.3 -9 -2
Trent Buy 6,498 7,642 18 2,310.0 27.4 17.6 24.6 33.6 49.5 69.1 94.5 131.4 94.0 68.7 77.1 55.3 40.7 26.8 28.5 39.5 -21 154
Vedant Fashion Buy 1,328 1,490 12 322.5 3.8 4.3 5.1 6.2 17.7 20.9 25.6 75.1 63.4 51.9 44.8 37.8 31.1 14.0 24.2 31.3 1 -1
V-Mart Retail Buy 3,538 5,101 44 70.0 0.8 -0.2 0.7 1.3 -11.3 35.3 67.3 -314.0 100.2 52.5 21.4 14.8 11.8 8.8 9.2 11.9 -19 108
Westlife Foodworld Hold 726 878 21 113.3 1.3 0.6 1.0 1.4 3.6 6.6 9.3 204.3 110.4 78.3 29.6 23.6 19.7 16.0 15.3 32.9 -17 -12
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 76
Valuation Guide
Company Reco CMP TP Return M. Cap M. Cap Net profit (INR bn) EPS (INR) P/E (x) EV/EBITDA (x) P/BV (x) RoE (%) RoCE (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 FY26 FY26 1m 12m
INDUSTRIALS
ABB Buy 6,802 8,624 27 1,441.4 17.1 17.7 20.8 26.1 83.6 98.3 123.2 81.3 69.2 55.2 63.8 53.8 42.7 16.9 26.5 36.1 -21 60
BHEL Buy 223 364 64 775.0 9.2 17.8 34.3 42.3 5.1 9.8 12.1 43.6 22.6 18.3 29.3 16.0 13.1 2.8 12.8 15.3 -17 63
Cummins India Buy 3,326 4,289 29 922.0 10.9 17.3 20.2 24.8 62.3 73.0 89.3 53.4 45.6 37.2 45.3 37.9 30.2 12.2 28.2 37.1 -9 87
Engineers India Buy 179 238 33 100.8 1.2 3.3 4.3 5.4 5.2 6.9 8.6 34.6 26.1 21.0 28.5 19.1 14.2 3.6 16.5 19.0 -8 22
GE T&D Buy 1,777 2,180 23 455.1 5.4 5.6 7.4 10.1 21.9 29.0 39.6 81.2 61.2 44.8 56.9 43.0 31.4 17.9 34.2 48.9 -1 360
Hitachi Energy Buy 12,121 17,315 43 513.7 6.1 3.6 7.7 12.2 84.0 183.0 288.6 144.2 66.2 42.0 84.2 45.1 29.3 23.9 41.2 56.6 -24 178
Honeywell Automation Buy 41,988 56,560 35 371.2 4.4 5.3 7.0 9.6 602.1 788.6 1,087.7 69.7 53.2 38.6 53.7 39.2 27.4 7.8 15.8 16.1 -16 13
KEC International Buy 966 1,075 11 257.1 3.0 7.5 12.0 17.3 29.1 46.7 67.2 33.2 20.7 14.4 16.9 12.7 9.0 4.3 22.8 24.1 -4 69
Kirloskar Pneumatic Buy 1,517 1,747 15 98.3 1.2 2.2 2.6 3.1 34.6 40.9 48.5 43.8 37.1 31.2 30.0 24.9 20.5 7.1 21.1 19.5 9 168
Kirloskar Oil Engines Buy 1,097 1,550 41 159.1 1.9 4.4 5.8 7.2 30.5 39.8 49.6 35.9 27.6 22.1 22.5 17.3 13.7 4.8 18.4 23.4 -8 96
Lakshmi Machine Works Hold 15,250 15,996 5 162.9 1.9 2.0 3.6 5.7 182.9 335.3 533.2 83.4 45.5 28.6 65.3 33.6 20.2 5.3 12.2 16.1 -11 18
Linde India Hold 6,688 7,201 8 570.4 6.8 4.8 6.6 9.4 55.8 77.5 110.8 119.8 86.3 60.4 73.4 54.3 38.6 13.4 16.5 20.6 -18 11
Larsen & Toubro Buy 3,548 4,204 18 4,878.4 57.8 162.2 226.2 276.7 115.8 161.5 197.6 30.6 22.0 18.0 20.3 15.7 12.8 4.1 19.8 14.8 0 16
Siemens Buy 6,705 8,827 32 2,387.6 28.3 31.0 41.9 59.2 87.0 117.7 166.2 77.1 57.0 40.3 58.6 43.0 30.2 13.2 24.8 33.7 -13 96
Thermax Hold 4,908 5,144 5 584.8 6.9 6.8 9.7 13.5 60.3 85.8 119.9 81.4 57.2 40.9 60.0 42.9 30.7 9.6 18.0 21.8 -4 69
Transformers & Rectifiers India Buy 890 861 (3) 133.6 1.6 1.5 3.1 4.7 9.6 19.5 29.7 93.2 45.6 30.0 47.4 25.6 17.9 9.6 23.2 31.6 9 370
DEFENCE
Bharat Dynamics Buy 979 1,579 61 358.9 4.3 5.8 11.0 14.7 15.9 30.1 40.1 61.6 32.5 24.4 64.6 26.7 18.9 7.7 25.5 26.0 -18 81
Bharat Electronics Buy 282 373 33 2,058.1 24.4 45.9 56.8 68.2 6.3 7.8 9.3 44.8 36.2 30.2 32.8 26.0 21.2 9.3 27.8 28.6 -1 96
BEML Buy 3,812 5,185 36 158.7 1.9 3.4 4.8 7.2 82.1 116.0 172.8 46.5 32.9 22.1 29.8 21.6 14.9 4.7 15.2 15.8 2 72
Cochin Shipyard Hold 1,317 1,627 24 346.6 4.1 7.6 8.5 10.4 28.9 32.4 39.7 45.6 40.6 33.2 28.1 25.0 20.4 5.7 14.8 19.3 -19 150
Garden Reach Shipbuilders Buy 1,384 2,092 51 158.6 1.9 4.4 5.3 5.4 38.3 46.0 47.0 36.1 30.1 29.4 29.6 22.7 20.7 6.5 23.2 31.8 -18 80
Hindustan Aeronautics Buy 4,067 6,184 52 2,719.8 32.2 67.9 85.9 97.9 101.6 128.5 146.4 40.0 31.7 27.8 28.0 21.2 17.6 7.0 23.8 24.8 -10 97
Mazagon Dock Shipbuilders Buy 3,891 5,513 42 784.7 9.3 28.6 30.1 38.5 141.6 149.4 190.8 27.5 26.0 20.4 23.6 20.3 13.1 7.4 31.6 43.9 -9 97
PTC Industries Buy 11,111 19,653 77 166.4 2.0 0.8 1.7 5.0 52.5 112.0 334.8 211.8 99.2 33.2 132.8 55.1 22.4 10.7 11.3 14.5 -18 125
CONSUMER DURABLES
Bajaj Elec. Hold 806 901 12 92.9 1.1 1.0 2.1 3.0 8.5 18.0 25.7 94.6 44.7 31.3 33.6 21.8 16.6 5.7 13.2 16.7 -11 -19
Blue Star Hold 1,760 1,946 11 362.0 4.3 6.4 8.9 11.3 31.3 43.1 55.0 56.3 40.8 32.0 37.5 27.5 21.6 9.3 25.2 32.3 -13 83
Crompton Consumer Buy 385 503 31 247.8 2.9 5.4 7.1 9.1 8.5 11.0 14.2 45.5 35.1 27.2 27.8 21.8 17.0 6.7 20.1 23.2 -10 38
Havells India Hold 1,614 2,000 24 1,011.9 12.0 15.7 19.8 25.0 25.2 31.7 40.0 64.1 51.0 40.4 44.0 34.9 27.5 10.0 21.2 27.9 -17 29
Voltas Hold 1,685 1,901 13 557.7 6.6 9.5 12.0 16.3 28.6 36.2 49.2 58.8 46.5 34.3 44.8 34.8 25.5 7.6 17.4 23.4 -6 107
RAILWAYS
IRCON International Hold 192 205 7 180.4 2.1 7.8 8.4 9.5 8.3 8.9 10.1 23.0 21.5 19.1 22.1 20.5 18.0 2.7 12.9 16.5 -14 21
Jupiter Wagons Ltd Hold 440 507 15 186.7 2.2 4.4 5.6 6.5 10.7 13.6 15.8 41.1 32.4 27.8 26.6 21.1 18.0 5.4 18.1 23.7 -16 38
RITES Hold 270 325 20 129.6 1.5 3.4 4.0 5.2 7.0 8.4 10.8 38.4 32.1 24.9 19.9 16.6 12.9 4.9 15.3 21.6 -13 18
Rail Vikas Nigam Ltd Sell 420 251 (40) 875.4 10.4 14.8 16.2 17.8 7.1 7.8 8.5 59.2 53.9 49.1 72.9 64.8 56.8 8.1 15.8 16.1 -11 168
Titagarh Rail Systems Buy 1,089 1,712 57 146.7 1.7 3.9 5.9 7.3 30.5 46.2 57.1 35.8 23.6 19.1 25.5 17.0 13.6 4.4 20.4 29.6 -3 33
INFRASTRUCTURE
Ahluwalia Contracts Hold 1,025 1,139 11 68.6 0.8 2.8 3.4 4.2 41.7 51.1 62.8 24.6 20.0 16.3 12.8 10.2 8.0 3.1 16.7 25.3 -5 52
Ashoka Buildcon Hold 233 253 8 65.5 0.8 2.5 3.6 4.8 8.8 12.7 17.3 26.5 18.3 13.5 13.0 10.4 8.5 1.5 8.4 13.2 -10 67
Dilip Buildcon Buy 477 652 37 69.8 0.8 3.6 5.3 7.0 22.3 32.7 42.8 21.4 14.6 11.1 6.6 5.6 4.7 1.2 8.8 16.0 -6 20
HG Infra Engineering Buy 1,198 1,792 50 78.1 0.9 5.1 5.9 6.9 78.1 90.0 106.0 15.3 13.3 11.3 9.2 8.1 6.9 2.3 18.9 22.8 -19 42
IRB Infra Buy 49 76 56 293.0 3.5 8.6 11.5 13.8 1.4 1.9 2.3 34.2 25.5 21.2 13.7 11.5 10.1 1.9 7.6 7.7 -17 39
KNR Constructions Ltd. Hold 308 286 (7) 86.5 1.0 3.5 3.6 4.1 12.3 12.9 14.6 25.0 23.9 21.1 13.6 12.8 11.2 2.2 9.7 13.9 -3 17
NCC Ltd. Buy 280 395 41 175.6 2.1 9.3 11.9 15.5 14.9 19.0 24.7 18.8 14.7 11.3 8.7 7.2 5.8 2.1 14.9 25.5 -6 69
PNC Infratech Buy 309 633 105 79.3 0.9 5.9 7.1 8.7 23.0 27.5 33.9 13.4 11.2 9.1 8.1 6.9 5.5 1.3 12.4 16.5 -31 -3
PSP Projects Buy 619 909 47 24.6 0.3 1.5 1.9 2.4 38.8 49.1 60.6 16.0 12.6 10.2 8.3 6.8 5.5 1.7 14.1 17.8 -4 -22
Welspun Ent. Hold 456 553 21 63.2 0.7 3.2 3.8 4.5 23.1 27.7 33.2 19.7 16.5 13.7 14.0 11.3 9.0 2.1 13.2 18.7 -17 46
IT
Cyient Hold 1,795 2,250 25 199.2 2.4 8.0 9.1 10.3 64.9 83.1 93.8 27.7 21.6 19.1 14.2 12.1 10.6 3.8 18.1 22.3 -3 8
FirstSource Sol. Buy 349 400 14 243.6 2.9 6.4 8.3 9.5 9.1 11.8 13.4 38.6 29.6 26.1 21.1 17.5 15.2 5.5 19.7 17.1 10 119
HCL Tech Buy 1,865 2,000 7 5,060.3 59.9 177.0 195.6 218.1 64.7 71.2 79.1 28.8 26.2 23.6 18.4 16.1 14.2 7.8 29.7 38.3 0 48
Infosys Hold 1,868 1,980 6 7,757.9 91.9 265.6 306.3 333.7 64.1 73.9 80.6 29.2 25.3 23.2 19.2 16.8 15.0 7.6 31.2 41.2 -5 37
LTI Mindtree Hold 5,948 6,675 12 1,761.6 20.9 51.0 57.4 65.7 172.4 194.0 222.1 34.5 30.7 26.8 24.4 20.4 17.6 6.7 23.3 31.3 -8 13
L&T Technology Services Hold 5,175 5,450 5 547.7 6.5 13.2 14.9 17.4 125.1 140.7 164.7 41.4 36.8 31.4 26.9 23.5 19.6 8.8 25.0 32.0 -2 22
Mphasis Buy 2,845 3,725 31 538.8 6.4 17.0 19.4 22.0 90.3 103.2 116.6 31.5 27.6 24.4 20.0 17.3 15.3 5.2 19.7 24.2 -4 32
Coforge Ltd Buy 8,056 8,400 4 537.5 6.4 10.3 14.4 16.9 155.2 216.3 253.9 51.9 37.2 31.7 26.6 22.1 18.9 11.2 32.7 41.9 8 58
Persistent Sys Hold 5,641 4,800 (15) 879.1 10.4 13.6 17.4 21.1 90.4 115.2 139.6 62.4 49.0 40.4 43.4 34.8 28.3 14.4 30.7 41.0 0 81
TCS Hold 4,150 4,425 7 15,016.3 177.9 501.1 565.7 617.2 138.5 156.4 170.6 30.0 26.5 24.3 20.8 18.8 17.1 12.1 48.3 60.4 0 25
TeamLease Buy 2,716 4,100 51 45.5 0.5 1.1 1.7 2.4 66.8 103.8 140.4 40.7 26.2 19.3 30.2 21.7 14.5 4.2 17.5 18.4 -10 9
Tech Mahindra Buy 1,676 1,875 12 1,639.5 19.4 46.4 56.5 67.5 52.4 63.8 76.1 32.0 26.3 22.0 20.6 16.8 14.3 6.0 22.3 31.2 -1 48
Wipro Hold 569 575 1 2,976.9 35.3 115.9 127.0 137.8 22.1 24.2 26.3 25.8 23.5 21.7 15.1 13.9 12.7 3.6 15.8 19.2 4 49
Zensar Technologies Buy 698 800 15 158.3 1.9 6.7 7.5 8.4 29.6 33.0 37.1 23.6 21.2 18.8 15.8 13.5 11.7 3.4 17.1 23.0 -3 43
contd...
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 77
Valuation Guide
Company Reco CMP TP Return M. Cap M. Cap Net profit (INR bn) EPS (INR) P/E (x) EV/EBITDA (x) P/BV (x) RoE (%) RoCE (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 FY26 FY26 1m 12m
METALS & MINING
APL Apollo Tubes Buy 1,498 1,718 15 415.8 4.9 7.1 11.3 17.0 25.6 40.7 61.4 58.5 36.9 24.4 35.5 24.5 17.2 8.1 24.3 27.4 -4 -11
Hindalco Industries Buy 627 794 27 1,408.1 16.7 131.6 122.7 128.1 59.2 55.2 57.6 10.6 11.4 10.9 6.2 6.4 6.1 1.1 9.7 11.6 -16 29
Hindustan Zinc Sell 486 419 (14) 2,052.2 24.3 106.8 116.1 123.5 25.3 27.5 29.2 19.2 17.7 16.6 11.4 10.5 9.9 11.1 68.6 57.4 -7 61
HI-Tech Pipes Buy 166 225 35 33.7 0.4 0.8 1.4 2.1 4.1 7.0 10.2 40.2 23.8 16.3 18.4 13.1 9.9 2.4 10.5 13.3 -16 45
Indian Hume Pipe Buy 416 579 39 21.9 0.3 0.7 1.0 1.2 13.2 18.6 22.9 31.5 22.3 18.1 16.8 13.7 11.8 2.2 10.5 13.2 -10 78
Jindal Steel & Power Buy 859 1,183 38 875.9 10.4 64.3 90.0 102.4 63.6 89.1 101.3 13.5 9.6 8.5 7.5 5.7 5.0 1.4 15.9 17.5 -14 35
JSW Steel Hold 936 909 (3) 2,288.8 27.1 89.6 135.8 157.3 36.8 55.7 64.6 25.4 16.8 14.5 10.9 8.7 7.8 2.5 15.5 13.7 -8 23
JTL Industries Buy 184 263 43 35.2 0.4 1.4 1.8 2.6 7.3 9.4 13.1 25.3 19.5 14.0 18.8 14.0 10.2 2.5 13.4 17.8 -14 -15
Kirloskar Ferrous Buy 607 797 31 99.8 1.2 4.0 5.8 8.7 24.5 35.4 52.8 24.8 17.2 11.5 12.0 9.4 6.9 2.5 15.3 17.3 -12 22
MOIL Buy 299 451 51 60.9 0.7 4.4 6.2 8.3 21.8 30.7 40.9 13.8 9.8 7.3 7.5 5.1 3.6 1.9 20.8 28.1 -21 11
NALCO Buy 220 236 7 403.5 4.8 27.1 32.8 33.6 14.8 17.9 18.3 14.9 12.3 12.0 8.6 7.1 6.7 2.2 18.7 24.0 -3 139
NMDC Buy 223 294 32 654.1 7.7 68.4 83.7 91.7 23.4 28.6 31.3 9.6 7.8 7.1 6.5 5.1 4.4 1.9 26.0 33.7 -6 27
SAIL Hold 112 130 16 461.3 5.5 38.3 45.8 50.3 9.3 11.1 12.2 12.1 10.1 9.2 6.9 6.2 5.8 0.7 7.5 8.2 -17 27
Tata Steel Buy 139 175 26 1,737.4 20.6 88.1 146.8 171.6 7.1 11.8 13.8 19.7 11.8 10.1 8.4 6.4 5.7 1.5 13.7 14.0 -12 15
Venus Pipes Hold 1,862 2,062 11 37.8 0.4 1.1 1.7 1.9 54.5 81.6 93.8 34.1 22.8 19.9 20.7 14.9 13.2 5.5 27.1 29.7 -7 27
Vedanta Hold 435 475 9 1,700.0 20.1 155.6 195.8 217.5 39.8 50.0 55.6 10.9 8.7 7.8 5.1 4.4 3.9 3.6 43.6 28.4 -13 80
OIL & GAS
BPCL Buy 306 405 32 1,326.9 15.7 138.5 140.3 142.9 31.9 32.3 32.9 9.6 9.5 9.3 6.2 6.4 6.8 1.5 16.1 16.3 -10 58
GAIL Sell 189 203 7 1,245.8 14.8 98.6 86.8 98.3 15.0 13.2 15.0 12.6 14.3 12.7 9.3 10.1 8.7 1.7 11.9 12.2 -18 50
Gujarat Gas Hold 492 579 18 338.5 4.0 12.0 17.0 18.7 17.4 24.7 27.2 28.2 19.9 18.1 16.4 11.9 10.7 3.5 18.9 22.6 -17 18
HPCL Buy 371 523 41 790.3 9.4 83.1 87.5 89.3 39.0 41.1 42.0 9.5 9.0 8.8 7.4 6.9 6.8 1.6 19.0 12.6 -8 84
IGL Hold 420 405 (3) 293.7 3.5 16.5 17.2 18.3 23.5 24.6 26.1 17.8 17.0 16.1 11.3 10.5 9.6 2.7 16.7 21.4 -19 7
Indian Oil Corp Buy 136 246 81 1,920.3 22.7 233.8 241.5 278.6 17.0 17.5 20.2 8.0 7.8 6.7 6.4 6.0 5.1 0.9 12.3 11.1 -18 37
Mahanagar Gas Hold 1,330 1,539 16 131.3 1.6 10.0 10.2 11.1 100.9 103.7 112.7 13.2 12.8 11.8 6.9 6.5 5.8 2.1 17.3 22.5 -26 28
Oil India Buy 481 659 37 782.2 9.3 66.3 69.7 83.8 40.7 42.8 51.5 11.8 11.2 9.3 8.2 7.4 5.9 1.5 13.9 15.9 -18 130
ONGC Buy 253 364 44 3,177.1 37.6 369.7 415.6 427.0 29.4 33.0 33.9 8.6 7.6 7.4 4.3 3.7 3.3 0.9 12.2 14.7 -12 29
Petronet LNG Hold 315 363 15 472.3 5.6 37.9 42.4 43.2 25.3 28.3 28.8 12.5 11.1 10.9 8.4 8.1 8.1 2.4 22.2 23.6 -11 59
Reliance Industries Hold 1,252 2,846 127 16,943.7 200.7 693.4 804.8 852.7 102.5 118.9 126.0 12.2 10.5 9.9 11.1 9.5 8.5 0.9 9.3 9.6 -9 8
PHARMA & HEALTHCARE
Alkem Hold 5,571 4,670 (16) 666.1 7.9 23.2 24.9 25.4 194.2 208.0 212.3 28.7 26.8 26.2 22.8 20.7 18.1 4.9 19.4 23.3 -11 30
Alembic Pharma Buy 1,020 1,411 38 200.4 2.4 6.2 7.8 11.1 31.5 39.9 56.4 32.4 25.6 18.1 18.6 15.1 11.3 3.4 13.9 17.3 -9 38
CIPLA Sell 1,506 1,204 (20) 1,215.9 14.4 32.6 36.6 40.4 40.4 45.4 50.2 37.2 33.2 30.0 23.1 20.2 17.8 3.7 11.8 16.5 -6 21
Concord Biotech Buy 1,854 2,187 18 193.9 2.3 3.7 4.9 6.5 35.1 46.7 62.5 52.9 39.7 29.7 37.9 28.1 20.8 9.1 25.0 32.6 -4 42
Divi's Laboratories Ltd Sell 5,770 4,150 (28) 1,531.8 18.1 21.2 26.3 29.7 79.8 99.2 112.0 72.3 58.1 51.5 50.4 39.8 34.9 9.4 16.9 22.1 -7 64
Dr Reddys Sell 1,245 1,190 (4) 1,038.8 12.3 32.1 41.7 47.8 38.5 50.0 57.3 32.3 24.9 21.7 18.1 13.9 12.4 3.6 14.7 18.3 -7 15
IOL Chemicals Buy 370 468 26 21.7 0.3 2.1 2.4 2.2 35.2 40.5 37.5 10.5 9.1 9.9 6.3 5.3 5.1 1.1 12.5 15.9 -14 -14
JB Chemicals Hold 1,715 1,679 (2) 266.4 3.2 7.5 8.5 9.7 48.1 54.7 62.2 35.6 31.4 27.6 22.0 19.2 16.6 3.3 22.7 28.0 -6 14
Laurus Labs Hold 477 398 (16) 257.0 3.0 4.2 6.9 8.6 7.8 12.7 15.9 61.2 37.5 29.9 23.5 17.5 14.7 5.1 14.3 15.2 0 28
Lupin Buy 2,039 2,259 11 930.2 11.0 31.3 38.9 43.4 68.7 85.4 95.3 29.7 23.9 21.4 17.9 14.8 12.9 4.6 20.9 26.1 -9 74
Mankind Pharma Buy 2,532 2,827 12 1,014.5 12.0 22.2 25.8 31.5 55.3 64.3 78.5 45.8 39.4 32.2 34.6 25.1 21.8 7.4 20.6 18.3 -8 38
Shilpa Medicare Buy 825 1,300 58 80.7 1.0 1.6 3.8 6.3 16.0 39.2 64.8 51.5 21.0 12.7 22.4 12.0 8.0 2.8 14.4 18.8 -4 126
Solara Active Pharma Sell 742 566 (24) 32.3 0.4 0.9 1.6 1.5 17.8 32.5 31.4 41.7 22.8 23.6 14.3 11.0 9.1 2.4 11.7 10.4 0 132
Torrent Pharma Buy 3,117 3,589 15 1,054.8 12.5 20.3 27.0 32.8 59.9 79.9 97.0 52.0 39.0 32.1 28.0 23.2 19.6 12.0 32.9 37.0 -11 51
Zydus Life Science Hold 964 1,033 7 969.8 11.5 37.0 40.3 42.7 36.8 40.0 42.5 26.2 24.1 22.7 17.4 15.4 13.9 3.7 16.3 19.9 -9 55
HOSPITALS & DIAGNOSTICS
Dr Lal Pathlabs Sell 2,957 2,461 (17) 247.2 2.9 4.4 5.1 5.9 52.4 61.2 70.3 56.5 48.3 42.0 34.4 29.6 25.8 51.0 22.5 29.5 -14 13
Metropolis Healthcare Sell 2,050 1,758 (14) 105.1 1.2 1.7 2.1 2.6 33.4 41.4 50.2 61.4 49.5 40.8 29.9 25.0 20.9 7.5 16.1 20.5 -10 27
Vijaya Diagnostic Centre Hold 1,017 930 (9) 104.4 1.2 1.6 2.1 2.6 15.6 20.2 25.3 65.4 50.3 40.1 35.4 28.0 22.4 5.3 23.1 26.0 3 63
REALTY
Arvind SmartSpaces Buy 863 1,159 34 39.3 0.5 0.7 1.1 1.5 17.1 26.8 36.2 50.5 32.2 23.8 30.8 20.6 16.1 5.4 18.2 24.2 0 146
Brigade Enterprise Buy 1,073 1,620 51 262.1 3.1 6.8 8.2 10.3 29.7 35.5 44.8 36.1 30.2 24.0 19.1 17.0 14.5 24.1 17.3 15.0 -16 53
Aditya Birla Real Estate Buy 2,558 3,804 49 285.7 3.4 2.8 4.2 4.6 25.5 37.6 41.5 100.3 68.0 61.6 35.0 27.7 25.2 6.3 9.6 11.2 -6 112
DLF Buy 749 1,014 36 1,852.9 21.9 37.4 44.4 56.5 15.1 17.9 22.8 49.5 41.8 32.8 71.8 59.6 56.6 3.9 9.8 7.0 -13 23
Godrej Properties Buy 2,569 3,826 49 714.4 8.5 13.2 30.5 39.6 47.3 109.6 142.5 54.3 23.4 18.0 115.8 62.1 49.9 5.0 23.7 19.2 -17 41
Kolte Patil Buy 360 618 72 27.4 0.3 1.4 1.5 1.9 18.0 20.0 25.1 20.0 18.0 14.4 6.4 5.9 5.4 2.8 16.8 17.7 -7 -27
Macrotech Developers Buy 1,202 1,413 18 1,197.9 14.2 29.3 33.8 39.5 29.5 34.0 39.8 40.7 35.4 30.2 29.2 25.9 22.2 5.0 15.3 16.1 -1 41
Nexus Select Trust Buy 142 172 22 214.7 2.5 6.6 7.5 8.8 4.3 4.9 5.8 32.7 28.8 24.4 15.8 14.3 13.6 1.6 5.3 7.2 -1 10
Oberoi Realty Buy 1,927 2,688 40 700.7 8.3 27.3 32.6 37.1 75.1 89.8 102.2 25.7 21.5 18.9 20.6 17.0 14.6 3.5 17.9 20.9 -4 56
Phoenix Buy 1,446 1,633 13 516.9 6.1 10.3 12.1 13.0 57.6 67.8 72.8 25.1 21.3 19.9 24.8 22.3 20.8 2.3 11.2 10.8 -10 37
Prestige Estates Buy 1,520 2,311 52 654.5 7.8 14.5 15.6 17.2 33.6 36.3 39.9 45.2 41.9 38.1 27.0 24.0 21.2 4.3 10.9 11.0 -18 80
Sobha Buy 1,547 3,003 94 155.2 1.8 3.4 5.9 8.2 31.5 55.1 76.7 49.1 28.1 20.2 24.3 16.2 12.0 4.3 18.7 21.9 -10 90
Sunteck Realty Buy 490 786 60 71.8 0.9 3.1 2.8 2.4 21.4 19.4 16.7 22.9 25.2 29.4 - - - 2.0 8.2 10.4 -12 10
TELECOM
Bharti Airtel Buy 1,550 1,822 18 9,274.1 109.8 218.4 309.4 407.7 38.1 54.0 71.2 40.7 28.7 21.8 12.3 10.2 8.4 7.1 27.5 19.8 -9 66
contd...
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 78
Valuation Guide
Company Reco CMP TP Return M. Cap M. Cap Net profit (INR bn) EPS (INR) P/E (x) EV/EBITDA (x) P/BV (x) RoE (%) RoCE (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 FY26 FY26 1m 12m
TEXTILE
Arvind Ltd Buy 336 529 57 88.1 1.0 3.8 5.8 7.2 14.4 22.1 27.6 23.4 15.3 12.2 10.8 8.2 6.8 2.0 13.7 16.1 -6 58
KPR Mills Hold 879 926 5 300.5 3.6 9.4 11.0 12.7 27.6 32.1 37.0 31.8 27.3 23.7 21.9 19.1 16.7 5.1 20.0 24.4 -6 15
Welspun Living Buy 149 216 45 142.7 1.7 9.0 11.0 13.1 9.2 11.3 13.5 16.1 13.2 11.0 9.2 7.7 6.3 2.3 18.6 19.0 -9 -6
UTILITIES
CESC Buy 175 203 16 231.9 2.7 16.9 18.7 21.3 12.7 14.1 16.0 13.8 12.4 10.9 10.9 8.0 7.2 1.7 17.2 12.0 -7 94
COAL India Buy 407 598 47 2,507.6 29.7 375.2 401.8 429.0 60.9 65.2 69.6 6.7 6.2 5.8 4.4 3.9 3.4 2.0 34.6 18.7 -18 16
Indian Energy Exchange Buy 163 282 74 145.1 1.7 4.0 4.8 5.6 4.5 5.4 6.3 36.1 30.4 25.9 30.6 25.4 21.1 11.3 40.1 42.3 -17 23
JSW Energy Hold 729 630 (14) 1,274.0 15.1 22.1 25.3 28.3 12.7 14.5 16.2 57.4 50.3 44.9 23.1 20.6 18.9 4.2 8.7 8.1 4 86
NHPC Hold 78 92 18 782.9 9.3 37.1 44.4 55.3 3.6 4.3 5.4 21.6 18.0 14.5 23.8 20.3 16.0 1.8 10.4 4.9 -14 49
NTPC Buy 381 477 25 3,697.8 43.8 179.4 206.1 237.4 18.5 21.3 24.5 20.6 17.9 15.6 12.2 11.0 10.0 2.2 12.5 9.8 -10 55
Power Grid Hold 318 333 5 2,957.6 35.0 153.0 162.9 174.4 16.4 17.5 18.8 19.3 18.2 17.0 10.2 9.9 9.5 3.0 17.2 13.4 -4 50
SJVN Ltd Hold 104 118 13 409.4 4.8 8.1 9.2 11.6 2.1 2.3 3.0 50.3 44.4 35.2 30.1 25.4 20.9 2.8 6.3 4.1 -13 36
Torrent Power Hold 1,645 1,150 (30) 790.7 9.4 24.1 26.4 30.4 50.1 54.9 63.2 32.8 30.0 26.0 17.1 15.6 14.0 5.2 18.2 14.1 -15 101
Tata Power Buy 399 513 29 1,276.1 15.1 49.0 59.6 71.0 15.3 18.7 22.2 26.0 21.4 18.0 13.8 12.0 10.7 3.2 14.7 8.4 -14 55
TRAVEL & LEISURE
Indian Hotels Hold 714 640 (10) 1,016.5 12.0 17.3 21.5 25.0 12.2 15.1 17.6 58.5 47.2 40.6 37.1 30.6 25.7 7.9 18.2 19.3 1 74
Chalet Hotels Buy 819 1,000 22 178.6 2.1 3.9 5.2 7.4 18.1 23.7 34.1 45.2 34.6 24.0 23.7 19.4 14.1 4.3 13.4 14.0 -8 37
Yatra Online Buy 112 159 42 17.5 0.2 0.5 1.0 1.1 3.4 6.1 7.2 32.5 18.4 15.5 16.8 10.2 8.3 2.0 11.2 13.2 -10 -19
MIDCAP DIVERSIFIED
CCL Products Buy 697 850 22 93.1 1.1 2.6 3.7 5.3 19.9 27.8 40.0 35.1 25.1 17.4 21.3 16.7 12.8 4.3 18.4 12.4 5 10
EPL Ltd. Buy 261 360 38 83.2 1.0 3.5 4.7 5.6 11.0 14.8 17.5 23.7 17.6 14.9 9.8 8.2 7.2 3.2 19.4 23.2 -1 35
Ganesha Ecosphere Buy 2,194 1,910 (13) 55.6 0.7 1.4 1.6 2.4 51.8 61.2 91.4 42.4 35.8 24.0 22.7 19.9 14.2 4.1 12.1 13.9 -4 158
Gravita India BUY 2,158 3,300 53 149.0 1.8 2.9 4.0 5.0 41.4 57.4 73.1 52.1 37.6 29.5 38.1 28.7 23.3 10.4 31.5 27.4 -15 87
Mold-Tek Packaging Buy 676 1,000 48 22.5 0.3 0.7 0.8 1.1 19.8 25.4 32.7 34.1 26.7 20.7 16.5 13.6 11.1 3.1 12.3 11.2 -8 -23
Solar Industries Hold 9,688 9,730 0 876.7 10.4 12.9 16.1 19.1 142.2 177.8 211.4 68.1 54.5 45.8 42.2 34.1 28.5 14.7 30.7 38.1 -14 56
Varun Beverages Buy 568 690 21 1,845.6 21.9 26.6 34.8 44.6 8.2 10.7 13.7 69.3 53.1 41.4 38.7 31.5 25.9 15.1 32.5 32.6 -4 41
Company Reco CMP TP Return M. Cap M. Cap Net profit (INR bn) BVPS (INR) P/BV (x)* NNPA Ratio (%) P/E (x) RoE (%) RoA (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 FY26 FY26 1m 12m
FINANCIALS
Axis Bank Buy 1,139 1,375 21 3,524.6 41.7 274.6 324.4 388.5 551.0 632.8 730.9 1.9 1.7 1.4 0.3 0.4 0.5 10.9 17.7 1.8 -2 11
Bank of Baroda Buy 243 315 30 1,258.2 14.9 185.7 208.3 230.5 227.6 259.7 295.4 1.1 0.9 0.8 0.7 0.7 0.8 6.0 16.5 1.1 -1 24
Canara Bank Buy 98 135 37 891.9 10.6 151.2 169.0 195.1 100.7 115.6 132.8 1.0 0.9 0.7 1.0 0.9 0.8 5.3 17.2 1.0 -6 22
City Union Bank Buy 171 190 11 126.4 1.5 10.4 11.8 12.4 125.8 140.0 155.1 1.4 1.2 1.1 1.3 0.9 0.9 10.8 11.9 1.4 11 19
DCB Bank Buy 114 165 45 35.6 0.4 6.4 7.8 8.9 171.6 194.7 221.5 0.7 0.6 0.5 1.1 1.1 1.2 4.6 13.6 1.0 -2 1
Equitas SFB Buy 63 110 76 71.5 0.8 6.7 11.0 13.8 57.1 64.6 73.9 1.1 1.0 0.8 0.7 0.9 0.9 6.5 15.9 1.8 -15 -35
Federal Bank Buy 199 220 10 488.9 5.8 41.1 47.0 56.6 135.1 151.0 168.7 1.5 1.3 1.2 0.6 0.6 0.7 10.3 13.5 1.2 1 30
HDFC Bank Buy 1,681 1,900 13 12,848.2 152.2 670.4 781.1 923.4 629.4 708.3 801.5 2.3 2.1 1.8 0.4 0.4 0.4 16.4 15.4 1.8 0 13
ICICI Bank Buy 1,254 1,400 12 8,845.0 104.8 450.5 490.8 555.0 382.9 438.8 502.0 2.7 2.3 2.0 0.6 0.7 0.6 17.9 16.8 2.1 2 34
IndusInd Bank Buy 1,037 1,825 76 807.6 9.6 95.3 115.1 137.8 901.11,018.01,155.8 1.2 1.0 0.9 0.6 0.6 0.7 7.0 15.4 1.8 -24 -31
Karur Vysya Bank Buy 212 270 28 169.0 2.0 18.4 20.0 22.8 144.6 166.0 190.7 1.5 1.3 1.1 0.3 0.4 0.4 8.5 16.0 1.5 4 33
Kotak Mahindra Bank Buy 1,688 2,000 19 3,355.6 39.7 162.5 145.6 172.7 562.2 632.7 716.4 2.3 2.0 1.7 0.4 0.5 0.6 23.0 12.3 2.0 -12 -3
L&T Finance Buy 136 220 62 339.0 4.0 30.8 37.9 45.0 103.5 114.9 128.5 1.3 1.2 1.1 0.6 0.6 0.6 8.9 14.0 2.9 -18 -6
Punjab National Bank Hold 101 130 30 1,155.7 13.7 152.4 183.8 198.5 102.2 114.7 128.2 1.0 0.9 0.8 0.5 0.5 0.5 6.0 15.4 1.0 -4 27
Shriram Finance Buy 2,854 3,500 23 1,073.1 12.7 85.0 99.7 116.1 1,473.7 1,689.1 1,948.0 1.9 1.7 1.5 2.8 2.8 2.9 10.8 16.8 3.3 -16 45
State Bank of India Buy 809 975 21 7,216.9 85.5 679.0 710.9 822.7 416.6 480.3 554.0 1.5 1.3 1.1 0.6 0.6 0.6 10.2 16.9 1.0 0 39
South Indian Bank Hold 23 32 40 59.2 0.7 9.9 10.9 13.8 35.8 39.5 44.1 0.6 0.6 0.5 1.5 1.5 1.5 5.4 11.1 0.8 -5 -3
Ujjivan Small Bank Buy 34 60 75 66.0 0.8 12.0 13.6 14.9 35.1 42.1 49.9 1.0 0.8 0.7 0.4 0.4 0.4 4.9 18.2 2.5 -14 -41
Union Bank of India Buy 116 170 47 882.9 10.5 154.8 167.1 179.8 134.2 150.0 166.9 0.9 0.8 0.7 1.0 1.1 1.2 5.3 15.4 1.0 1 3
*Adjusted for subsidiaries
Company Reco CMP TP Return M. Cap M. Cap VNB (INR bn) EVPS (INR) P/EV (x) P/VNB (x) RoEV (%) Absolute (%)
(INR) (INR) (%) (INR bn) (USD bn) FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY25 FY26 FY27 FY26 1m 12m
Insurance
HDFC Life Insurance Buy 685 870 27 1,474.6 17.5 40.5 48.2 56.9 260.8 301.2 347.6 2.6 2.3 2.0 23.8 18.2 13.6 16.4 -8 10
ICICI Prudential Life Insurance Buy 688 865 26 994.0 11.8 26.1 30.9 35.9 343.3 390.7 444.4 2.0 1.8 1.5 20.2 14.8 10.6 14.5 -7 31
LIC of India Buy 898 1,260 40 5,679.2 67.3 111.5 121.8 130.9 1,330.1 1,460.1 1,597.7 0.7 0.6 0.6 NA NA NA 10.8 -6 48
Max Life Insurance* Buy 1,198 1,540 29 413.3 4.9 22.3 26.9 32.1 741.2 874.7 1,031.5 2.5 2.1 1.8 18.0 13.2 9.4 18.5 0 30
SBI Life Insurance Buy 1,547 2,060 33 1,549.7 18.4 59.4 69.9 81.9 709.1 832.4 976.3 2.2 1.9 1.6 14.5 10.6 7.3 17.8 -11 16
*Valuations after factoring 20% holdco discount
ANTIQUE STOCK BROKING LIMITED FROM THE RESEARCH DESK 14 November 2024 | 79
Important Disclaimer:
This report has been prepared by Antique Stock Broking Limited (hereinafter referred to as ASBL) to provide information about the company(ies) and/sector(s), if any, covered in the report and may be distributed
by it and/or its affiliated company(ies).
ASBL is a Stock Broker having SEBI Registration No. INZ000001131 and Depository Participant having SEBI Registration No. IN-DP-721-2022(CDSL) registered with and regulated by Securities & Exchange Board
of India. SEBI Registration Number: INH000001089 as per SEBI (Research Analysts) Regulations, 2014. CIN: U67120MH1994PLC079444.
ASBL and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group.
This report is for personal information of the selected recipient/s and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement
to invest in securities or other investments and ASBL is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should
not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs
of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice.
The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future
performance, future returns are not guaranteed and a loss of original capital may occur.
We and our affiliates have investment banking and other business relationships with a some companies covered by our Research Department. Our research professionals may provide input into our investment banking
and other business selection processes. Investors should assume that ASBL and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of
this material and that the research professionals who were involved in preparing this material may educate investors on investments in such business. The research professionals responsible for the preparation of
this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting information. Our research professionals are paid on the profitability
of ASBL which may include earnings from investment banking and other business.
ASBL generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover.
Additionally, ASBL generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders,
and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary
trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing
among other things, may give rise to real or potential conflicts of interest. ASBL and its affiliated company(ies), their directors and employees and their relatives may; (a) from time to time, have a long or short position
in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation
or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with
respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations
made by the analyst(s) are completely independent of the views of the affiliates of ASBL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report
Reports based on technical and derivative analysis center on studying charts company's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and,
as such, may not match with a report on a company's fundamental analysis. In addition ASBL has different business segments / Divisions with independent research separated by Chinese walls catering to different
set of customers having various objectives, risk profiles, investment horizon, etc, and therefore may at times have different contrary views on stocks sectors and markets.
Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt ASBL or any of its affiliates or
employees from, any and all responsibility/liability arising from such misuse and agrees not to hold ASBL or any of its affiliates or employees responsible for any such misuse and further agrees to hold ASBL or
any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained
herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent ASBL's interpretation of the data, information and/
or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete
statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, ASBL and/or its affiliates are under
no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent ASBL and/or its affiliates from doing so. ASBL or any of its affiliates or employees shall not
be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. ASBL or any of its affiliates or employees do not
provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose,
and non-infringement. The recipients of this report should rely on their own investigations.
This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based
on this report or for any necessary explanation of its contents.
ASBL and it's associates may have managed or co-managed public offering of securities, may have received compensation for investment banking or merchant banking or brokerage services, may have received
any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months.
ASBL and it's associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
Subject Company may have been a client of ASBL or its associates during twelve months preceding the date of distribution of the research report
ASBL and/or its affiliates and/or employees and /or relatives may have interests/positions, financial or otherwise of over 1 % at the end of the month immediately preceding the date of publication of the research
in the securities mentioned in this report. To enhance transparency, ASBL has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed
in the report.
There are no material disciplinary action that been taken by any regulatory authority impacting equity research analysis activities
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be
directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation
of ASBL research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues
Disclosure of Interest Statement Companies where there is interest
l Analyst ownership of the stock - No
l Served as an officer, director or employee - No
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject ASBL & its group companies to registration or licensing requirements within such jurisdictions.
For U.S. persons only: This research report is a product of Antique Stock Broking Limited, which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing
the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-
dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject
company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Antique Stock Broking Limited only to "Major Institutional Investors" as defined
by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient
of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted
onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order
to conduct certain business with Major Institutional Investors, Antique Stock Broking Limited has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo").
Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.
Compliance/Grievance officer: Ms. Jayshree Thakkar, Contact No: 022-69113461, Email id: [email protected]/[email protected]
Disclaimer that:
l Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
l The securities quoted are for illustration only and are not recommendatory.
l Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.